Kernel Methods in Computer-Aided Constructive Drug Design by Wong, William Wai Lun





presented to the University of Waterloo
in fulfilment of the




Waterloo, Ontario, Canada, 2009
c©William W.L. Wong 2009
I hereby declare that I am the sole author of this thesis. This is a true copy of the
thesis, including any required final revisions, as accepted by my examiners.
I understand that my thesis may be made electronically available to the public.
ii
Abstract
A drug is typically a small molecule that interacts with the binding site of some
target protein. Drug design involves the optimization of this interaction so that the
drug effectively binds with the target protein while not binding with other proteins
(an event that could produce dangerous side effects). Computational drug design
involves the geometric modeling of drug molecules, with the goal of generating
similar molecules that will be more effective drug candidates. It is necessary that
algorithms incorporate strategies to measure molecular similarity by comparing
molecular descriptors that may involve dozens to hundreds of attributes. We use
kernel-based methods to define these measures of similarity. Kernels are general
functions that can be used to formulate similarity comparisons.
The overall goal of this thesis is to develop effective and efficient computational
methods that are reliant on transparent mathematical descriptors of molecules with
applications to affinity prediction, detection of multiple binding modes, and gener-
ation of new drug leads. While in this thesis we derive computational strategies for
the discovery of new drug leads, our approach differs from the traditional ligand-
based approach. We have developed novel procedures to calculate inverse mappings
and subsequently recover the structure of a potential drug lead. The contributions
of this thesis are the following:
1. We propose a vector space model molecular descriptor (VSMMD) based on
a vector space model that is suitable for kernel studies in QSAR modeling.
Our experiments have provided convincing comparative empirical evidence
that our descriptor formulation in conjunction with kernel based regression
algorithms can provide sufficient discrimination to predict various biological
activities of a molecule with reasonable accuracy.
iii
2. We present a new component selection algorithm KACS (Kernel Alignment
Component Selection) based on kernel alignment for a QSAR study. Kernel
alignment has been developed as a measure of similarity between two kernel
functions. In our algorithm, we refine kernel alignment as an evaluation tool,
using recursive component elimination to eventually select the most important
components for classification. We have demonstrated empirically and proven
theoretically that our algorithm works well for finding the most important
components in different QSAR data sets.
3. We extend the VSMMD in conjunction with a kernel based clustering al-
gorithm to the prediction of multiple binding modes, a challenging area of
research that has been previously studied by means of time consuming dock-
ing simulations. The results reported in this study provide strong empirical
evidence that our strategy has enough resolving power to distinguish multiple
binding modes through the use of a standard k-means algorithm.
4. We develop a set of reverse engineering strategies for QSAR modeling based
on our VSMMD. These strategies include:
(a) The use of a kernel feature space algorithm to design or modify descriptor
image points in a feature space.
(b) The deployment of a pre-image algorithm to map the newly defined
descriptor image points in the feature space back to the input space of
the descriptors.
(c) The design of a probabilistic strategy to convert new descriptors to mean-
ingful chemical graph templates.
The most important aspect of these contributions is the presentation of strate-
iv
gies that actually generate the structure of a new drug candidate. While the training
set is still used to generate a new image point in the feature space, the reverse engi-
neering strategies just described allows us to develop a new drug candidate that is
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Drugs are molecules that are used as medications or as components in medicines to
diagnose, cure, mitigate, prevent, or treat diseases. To determine whether a drug
is useful, several complicated processes have to be undertaken. These processes
include:
1. investigations of biological activities of the drugs;
2. determination of the drug’s absorption, transport and distribution properties;
3. studies of the metabolic transformation of the drugs into other chemicals and
their excretion.
As shown in Figure 1.1.1, the drug discovery process in general can be divided
into three main stages: target identification, lead discovery, and clinical trials.
1
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Figure 1.1.1: Drug Discovery Process
• Target Identification. A drug discovery process begins with a known target
(usually a protein) that is related to a disease of interest. The target typically
has already been identified and shown to have importance in the disease
mechanism through biological or genetic investigations.
• Lead Discovery. The second step in the process is to discover a lead
molecule. This process begins with the development of an assay to look for
a modulator. A modulator can be an inhibitor, an antagonist, or an agonist
of the target’s activity. Following a high-throughput screening (HTS) of a
large number of small molecules, one or several small molecules can be iden-
tified. Elaboration of the initial small list of molecule hits through medicinal
chemistry is next used to improve the potency so as to produce a poten-
tial lead molecule. Among approximately 1060 possible molecules [57], only a
small portion will be considered for drug development. To speed up the whole
screening process, computational techniques such as quantitative structure ac-
tivity relationship (QSAR), computer-aided drug design and structure-based
drug design are widely used to rapidly generate hundreds of derivative com-
pounds from a common scaffold in the hit-to-lead optimization stage. The
next step is to optimize the lead molecule to get a candidate drug. In this
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process, chemists have to select the exact compounds that fulfill all the re-
quirements related to potency, absorption, bioavailability, metabolism and
safety.
• Clinical Trials. From the selected candidate molecules, drugs are produced
and given to animals for the preclinical safety studies. After this, an officially
proven new drug is required to pass three clinical trials on human beings. In
phase 1, studies on healthy subjects are conducted to confirm safety. In phase
2, studies are conducted on patients to confirm efficacy. Finally in phase 3,
large studies on patients are conducted to gather information about safety
and efficacy at the population level.
Drug discovery is a time consuming and costly process. On average, it takes 12
- 15 years to release a new drug to the market. The average cost for developing
a new drug is about 600−800 million dollars [1]. Among 10,000 drugs that are
applied on animals, only tens of them are left for human clinical trials. With good
fortune, one of them can be successfully put into the market. In many cases, none
of them can qualify.
1.2 Computer-Aided Drug Design
Computer-Aided Drug Design (CADD) is a specialized discipline that uses com-
putational knowledge-based methods to aid the drug discovery process. There are
several key areas where CADD plays an important role in the traditional drug
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discovery process. Genomics and bioinformatics support genetic methods of tar-
get identification and validation. Chemoinformatics techniques enable researchers
to process millions of virtual compounds for selection for synthesis and screening.
This allows researchers to make better decisions faster in the arena of drug lead
identification and optimization. ADMET (absorption, distribution, metabolism,
excretion, and toxicology) modeling aids researchers to identify a bioavailable drug
with suitable drug metabolism properties.
CADD methods offer significant benefits for drug discovery. They include:
• Time and Cost Savings. Virtual screening, lead optimization and pre-
dictions of bioavailability and bioactivity can guide experimental research.
Only the most promising drug candidates will be tested and experimental
dead-ends can be avoided early based on the results of CADD.
• Provide Insight. CADD provides deep insight on drug-receptor interac-
tions. For example: molecular models of drug compounds can reveal intrinsic,
atomic scale binding properties that are difficult to envision for researchers.
In general, CADD can be divided into two different strategies: structure-based
and ligand-based. Structure-based design usually starts with the structure of a
receptor site, such as the active site in a protein. Ligand-based design relies on
a set of ligands with known activities interacting with the same receptor and is
particularly valuable if no structural information is available for the binding site.
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1.2.1 Structure-Based Design
The preliminary step in structure-based drug design is to determine the three di-
mensional structure of a target molecule. This can by achieved by X-ray crystal-
lography or NMR spectroscopy experiments. Or, it can be approximated by some
computational methods such as comparative modeling1 and ab initio modeling2.
Given the three dimensional image of a target molecule (receptor), one needs to
identify the location of its binding site. The actual binding site can be located
by comparing with known protein-ligand complexes or through homology compar-
isons to related complexes. With a well determined binding site, a ligand can be
determined.
Usually, a ligand can be determined either through de novo design3 or through a
database search for a molecule that matches to the binding site. Docking methods
are then used to evalute the quality of the ligand. There are three tasks that a
docking procedure is required to address:
• characterizing the binding site;
• positioning the ligand into the binding site;
• evaluating the strength of interaction for a specific ligand-receptor complex.
1Comparative protein modelling uses previously solved structures as starting points to deter-
mine the three-dimensional structure of a protein
2Ab initio protein modelling methods seek to build three-dimensional protein models based on
physical principles rather than previously solved structures.
3De novo design involves creating new ligand from scratch by connecting possible atoms or
molecular fragments for a particular receptor and evaluating their quality.
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1.2.2 Ligand-Based Design
Ligand-based design methods are based on the fact that ligands similar to an active
ligand are more likely to be active than random ligands. Ligand-based design
usually starts with a database containing a set of molecules with known activities
interacting with the same receptor. A domain expert is required to construct this set
of molecules from the database. The domain expert is also responsible for dividing
the set of molecules into training and testing sets if necessary. The second step of
the ligand-based design is molecular modeling. Ligand-based approaches commonly
consider descriptors based on chemistry, shape, electrostatic, and interaction points
(e.g., pharmacophore points) to assess similarity. A pharmacophore is an explicit
geometric hypothesis of the critical features of a ligand [65]. Features usually include
hydrogen-bond donors and acceptors, charged groups and hydrophobic patterns.
The hypothesis can be used to screen databases for candidate compounds and also
can be used to refine existing leads. In Chapter 2, we will dicuss this concept in
more detail.
The third step of the ligand-based design usually involves setting up a computa-
tional model to identify the most promising molecule as a lead molecule for further
experimental investigation. A common method is the Quantitative Structure Ac-
tivity Relationships (QSAR) modeling for identifying a lead molecule. The concept
of QSAR is based on the fact that the biological properties of a compound can be
expressed as functions of its physicochemical parameters. Popular physicochemical
parameters of a compound include its solubility, lipophilicity, electronic effects, and
ionization. The goal of QSAR studies is to predict the activity of new compounds
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based solely on these parameters.
The last step is to identify the lead molecule from the results of the computa-
tional model. Figure 1.2.2 is a schematic presentation that summarizes the general
steps involved in ligand-based drug design.
Figure 1.2.2: General steps involved in ligand-based drug design.
1.3 Contributions of the thesis
The structural conformation and physicochemical properties of both the ligand
and its receptor site determine the level of binding affinity that is observed in such
an interaction. If the structural properties of the receptor site are known (for
example, there is crystallographic data), techniques involving approximations of
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potential functions can be applied to estimate or to compare binding affinities of
various ligands. When this information is sparse or not available, as is the case for
many membrane proteins, it becomes necessary to estimate affinities using only the
properties of the ligand. In this case, one strives to design a drug by improving
the chemical structure of a ligand that has been observed to successfully interact
with the protein. So, in this thesis, we focus on the development of ligand-based
prediction algorithms. We assume that all the training samples are processed using
only ligand properties with no explicit dependency on the nature of the protein
binding site.
1.3.1 Contributions to the traditional ligand-based approach
Following the traditional ligand-based approach that we have described in Figure
1.2.2, the main concerns of this approach can be categorized into the following
issues: formation of descriptors, component selection, and computational modeling
issues.
• Formation of descriptors: The manipulation and analysis of chemical
structural information of a ligand is made possible through the use of a molec-
ular descriptor. These are numerical values that characterize properties of the
ligand. For example, they may represent both the reaction centers and their
relationship to one another in a three-dimensional setting.
• Component selection: High dimensionality of descriptors poses a challenge
for statistical learning algorithms used to formulate predictors. The minimum
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number of samples required to ensure a high level of prediction confidence
rapidly increases as the dimensionality of the descriptors increases. We need
computational strategies to do component selection, keeping only those com-
ponents in the initial version of a molecular descriptor that are useful for later
study.
• Computational modeling issues: A good computational model should
address the following issues:
1. Ligand binding affinities depend on molecular descriptors in a nonlinear
fashion.
2. Data sets for ligand-based approach are usually not balanced. It is a
typical case that training data contains a large number of samples in the
negative class (ligands not binding to the protein) and a much smaller
number of samples in the positive class (ligands that show a high affinity
binding).
3. Many data are poor in quality. A poor quality data set may be due to
errors in wet lab observations. A good computational model should be
robust when applied to such a noisy data set.
In this thesis, we use kernel methods to implicitly define a nonlinear mapping from
the input space of molecular descriptors to a high dimensional feature space of image
points. Thus, a linear predictor defined in the feature space defines a nonlinear
predictor for the input space of descriptors. Kernel methods are also known to
behave well in comparison to other statistical or machine learning methods when
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dealing with high-dimensional noisy data [87]. Furthermore, kernel methods can
be modified to handle unbalanced data. This approach addresses the issues related
to computational modeling.
The contributions of this thesis to the traditional ligand-based approach are the
following:
• Contribution 1: We propose a vector space model molecular descriptor
(VSMMD) based on a vector space model that is suitable for kernel studies
in QSAR modeling. Our experiments have provided convincing compara-
tive empirical evidence that our descriptor in conjunction with kernel based
regression algorithms can provide sufficient discrimination to predict various
biological activities of a molecule with reasonable accuracy. This contribution
addresses the issues related to formation of a descriptor.
• Contribution 2: We present a new component selection algorithm KACS
(Kernel Alignment Component Selection) based on kernel alignment for a
QSAR study. Kernel alignment has been developed as a measure of similar-
ity between two kernel functions. In our algorithm, we refine kernel alignment
as an evaluation tool, using recursive component elimination to eventually se-
lect the most important components for classification. We have demonstrated
empirically and proven theoretically that our algorithm works well for finding
the most important components in different QSAR data sets. This contribu-
tion addresses the issues related to component selection.
Figure 1.3.3, an extension of Figure 1.2.2, includes the use of kernel methods in
the traditional ligand-based drug design. The kernel-based traditional ligand-based
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drug design involves the following steps:
1. The approach starts with a database of molecules. In this step, we say that
the molecules are in a chemical space 4.
2. A domain expert is involved to select a set of molecules with known activities
interacting with the same receptor. The domain expert is also responsible for
dividing the set of molecules into training and testing sets.
3. Initial molecular descriptors are generated for the training set.
4. A component selection algorithm is used to select the most important com-
ponents of the initial descriptors. Once these component positions are deter-
mined for the descriptor vector, these components are used across all initial
descriptors of the training set to get the final descriptors.
5. Kernel methods are used to map the input space of the final descriptors to
high dimensional feature space of image points.
6. A predictor can be defined and trained in the feature space.
7. Generate initial molecular descriptors for the testing set. Final descriptors are
then constructed using the best component selection strategy as determined
by the training set. The predictor defined in step 6 will be used to assess the
testing set.
4In this thesis, chemical space is defined as the space that encompasses all the small molecules
that could in principle be created.
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Figure 1.3.3: Kernel-based traditional ligand-based drug design.
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1.3.2 Contributions to improve the traditional ligand-based
approach
The traditional ligand-based approach involves several relevant issues and problems
that have not yet been addressed. This includes issues related to: multiple binding
modes, library dependence, and reverse engineering of a molecular descriptor.
• Multiple binding modes. The ligand may show evidence of multiple bind-
ing modes within the same binding site. The same ligand can bind in distinct
orientations or conformations in the binding site. The information of binding
affinities for each mode are usually combined and packed as a whole in the
training set. To disentangle this information is a challenge and thus compli-
cates the machine learning strategy.
• Library dependence.
Statistical learning theory [95] asserts the success of a predictor only when
the test sample is drawn from a data source that has the same probabil-
ity distribution as that characterizing the training set. More precisely, the
components of the descriptors must have the same probability distribution in
both training and testing set. In traditional ligand-based drug design, we can
define various data sets: training data set, validation data set, testing data
set and application data set. The first two data sets are used to derive the
predictor and the testing data set is used to get a measure of success for the
predictor. Note that in all these cases, we know the affinities of the ligand
and it is likely that the probability distribution constraint can be met. The
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application data set is the set of ligands on which the predictor will be used
in the future to get a new drug candidate. For this set, we do not know the
affinities. It is usually difficult for one to guarantee the probability distribu-
tion constraint. In this case, the predictor is often applied to molecules that
have very little relationship to the training data.
• Reverse engineering of a molecular descriptor. Ideally, a good molec-
ular descriptor should not only be able to capture important molecular prop-
erties, it should also be able to represent these properties in a transparent
fashion. In particular, we want descriptors that facilitate the implementation
of recovery algorithms that can accept a newly computed descriptor as input
and subsequently compute a new ligand corresponding to this new descriptor.
The contributions of this thesis to improve the traditional ligand-based approach
are the following:
• Contribution 3: Traditionally, the assumption of similar analogs binding to
the same binding site in a similar binding model is often employed in QSAR
studies [55] . In the QSAR modeling process, data from molecules with
alternate binding modes in a binding site are completely ignored or treated
as outliers. However, the ability of predicting the correct binding modes of
active compounds identified from high-throughput or virtual screening will
facilitate the drug discovery process. In conjunction with a kernel based clus-
tering algorithm, we extend the VSMMD to the prediction of multiple binding
modes. The results reported in this study provide strong empirical evidence
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that our strategy has enough resolving power to distinguish multiple binding
modes through the use of a standard k-means algorithm. This contribution
addresses the issue related to the multiple binding modes.
• Contribution 4: We have developed a set of reverse engineering strategies
for QSAR modeling based on our VSMMD. These strategies include:
1. The use of a kernel feature space algorithm to design or modify descriptor
image points in a feature space.
2. The deployment of a pre-image algorithm to map the newly defined
descriptor image points in the feature space back to the input space of
the descriptors.
3. The design of a probabilistic strategy to convert new descriptors into
meaningful chemical graph templates.
The most important aspect of these contributions is the presentation of strate-
gies that actually generate the structure of a new drug candidate. While the train-
ing set is still used to generate a new image point in the feature space, the reverse
engineering strategies just described allow us to develop a new drug candidate that
is independent of issues related to the probability distribution constraints placed
on the testing or application set. This contribution addresses the issues related to
library dependence and reverse engineering of a molecular descriptor.
Figure 1.3.4 summarizes our ligand-based constructive drug design approach.
Our approach involves the following steps:
1. The approach starts with a database of molecules in chemical space.
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2. A domain expert is involved to select a set of molecules with known activities
interacting with the same receptor.
3. Initial molecular descriptors are generated for the training set.
4. A component selection algorithm is used to select the most important com-
ponents of the initial descriptors. Once these component positions are deter-
mined for the descriptor vector, these components are used across all initial
descriptors of the training set to get the final descriptors.
5. Kernel methods are used to map the final descriptors in the input space to a
high dimensional feature space of image points.
6. A predictor can be defined and trained in the feature space. A test set may
be used to gain confidence in the predictor.
7. A new image point in the feature space can be defined using an appropriate
kernel feature space algorithm.
8. A kernel pre-image method is used to calculate the inverse mapping of the
new image point back to the input space of the descriptors and thus derive
the descriptor for the new drug lead.
9. A probabilistic algorithm is used to convert the descriptor for the drug lead
to a meaningful chemical graph template.
10. Based on the chemical graph template, lead molecules can be identified by
means of high-throughput screening.
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Figure 1.3.4: Our ligand-based constructive drug design approach.
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The overall goal of this thesis is to develop effective and efficient computational
methods that are reliant on transparent mathematical descriptors of molecules with
applications to affinity prediction, detection of multiple binding modes, and gen-
eration of new drug leads. While in this thesis we derive computational strate-
gies for the discovery of new drug leads, our approach differs from the traditional
ligand-based approach. We have developed novel procedures to calculate an inverse
mapping and subsequently recover the structure of a potential drug lead.
The layout of this thesis is as follows: In chapter 2, we will introduce some
relevant prior studies on molecular descriptors, QSAR, and kernel methods. In
chapter 3, we introduce our vector space model molecular descriptor (VSMMD). In
chapter 4, we will focus on component selection and our newly proposed method
Kernel Alignment Component Selection (KACS) will be presented. In chapter 5,
we extend the VSMMD in conjunction with a kernel based clustering algorithm
to the prediction of multiple binding modes. In chapter 6, we present our reverse
engineering strategies for QSAR modeling based on our VSMMD. Conclusion and




In this chapter, we will overview some relevant prior studies on the two key com-
ponents in traditional ligand-based drug design: They are molecular modeling and
computational modeling.
2.1 Molecular Modeling
The manipulation and analysis of chemical structural information of a ligand is
made possible through the use of molecular descriptors. These are numerical values
that characterize properties of the ligand. A successful traditional ligand-based drug
design approach critically depends on the accurate definition and the appropriate
use of molecular descriptors [87]. In this section, we will overview some existing
descriptors.
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Molecular descriptors can be categorized as empirical descriptors or theoretical
descriptors [87]. The empirical descriptors are those that can be obtained from
some experimentally measured data that usually include thermodynamic, kinetic,
chemical and physical data. The theoretical descriptors are usually derived from the
chemical structure of a molecule and are expressed with an explicit mathematical
formula that is based on fundamental physical attributes of the molecule.
In general, theoretical descriptors can be classified into different classes based
on their complexity or the method of calculation. They include constitutional
descriptors, topological descriptors, geometrical descriptors, charge-distribution-
related descriptors, molecular-orbital-related descriptors, temperature dependent
descriptors, solvation descriptors, and mixed descriptors. We will limit our overview
to a brief description of the first three types of descriptors.
The simplest class of theoretical descriptors is the set of constitutional descrip-
tors. They are constructed based on simple counts of features, such as hydrogen
bond donors, hydrogen bond acceptors, aromatic rings, number of rotatable bonds,
and molecular weight.
The topological descriptors are single valued functions that can be calculated
from the two-dimensional graphical representation of molecules. The descriptor
describes the structure according to the molecule’s size, degree of branching, and
overall shape. Example of topological descriptors include the Wiener index [110],
the branching index [65], and chi molecular connectivity indices [52].
Geometrical descriptors are derived from the three-dimensional structure of the
molecules. The properties of a molecule depend on how its atoms can be positioned
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in space to produce its three-dimensional structures or conformations. The quality
of a geometrical descriptor depends heavily on the quality of these conformations.
Molecular surface area is one of the more useful geometrical descriptors. Other
popular geometrical descriptors include molecular volume and the solvent-excluded
volume.
A pharmacophore is defined as a set of critical features in a molecule together
with their relative spatial orientations. These features usually include hydrogen-
bond donors and acceptors, charged groups and hydrophobic centers. We often
refer to these features as pharmacophore points. The spatial relationships be-
tween the features are usually specified by all possible inter-point distances between
chosen pharmacophore points. The pharmacophore is usually derived from three-
dimensional computed conformations of a molecule and is an abstract representa-
tion of the molecule. A simple example of a three-point pharmacophore based on
inter-point distances is given in Figure 2.1.1. Three-point pharmacophores have tra-
ditionally been used as descriptors for many applications such as high-throughput
screening and QSAR modeling [65].
2.2 Computational Modeling
2.2.1 Quantitative Structure-Activity Relationship
In ligand-based design, a computational model is required to identify the most
promising molecule as a lead molecule for further experimental investigation. In a
more general setting, we strive to establish the quantitative dependency between
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Figure 2.1.1: An example of three-point pharmacophore.
the molecular properties of a ligand and its binding affinity. To restate this goal
using current terminology: we want to analyze the Quantitative Structure-Activity
Relationship (QSAR) of the ligand with respect to a particular type of receptor. A
common approach for a QSAR analysis is the use of a machine learning strategy
that processes sample data to learn a function that will predict binding affinities.
The input of such a function is a molecular descriptor that was described in the
previous section.
2.2.2 Historical Background
The concept of QSAR was first introduced [88] in 1868, when a QSAR was mod-
eled [18] using the equation σ = f(C) where the physiological activity σ was ex-
pressed as a function of the chemical structure C.
Later quantitative approaches combined different physicochemical parameters in
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a linear additive manner [40] followed by Free and Wilson who formulated structure-
activity dependencies using the equation: AB = u +
∑
i aixi where AB is the bio-
logical activity, u is the average contribution of the unsubstituted parent molecule
of a particular series (for example, a scaffold), the ai values are the contributions
of various structural features, and the xi values denote the presence or absence of a
particular fragment [27]. Since then, QSAR has remained a thriving research area
in drug design.
More recently developed QSAR modeling approaches include HQSAR [69], In-
verse QSAR [13] and Binary QSAR [29]). The accuracy of QSAR modeling is
greatly improved by using sophisticated statistical and machine learning meth-
ods, for example, partial least square (PLS) [21] and support vector machines
(SVM) [104].
2.2.3 Deriving a QSAR Equation: Kernel Methods
Various mathematical methods have been used to derive QSAR models. These
methods can be categorized into linear and non-linear methods.
• Linear Methods. A linear method defines a linear relationship between the
activity level and the molecular descriptors to establish the structure-activity
relationship. There are several commonly used linear methods in QSAR mod-
eling. They include multiple linear regression (MLR) [115, 103, 45], partial
least squares (PLS) [99], and linear discriminant analysis (LDA) [34].
• Non-linear Methods. Non-linear methods establish the structure-activity
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relationship using a non-linear function. Common non-linear methods in-
clude: Bayes classifier [99], k-nearest neighbors [47], neural networks [96] and
kernel methods [4]. These methods generally provide more accurate results,
especially for a large and diverse dataset.
Kernel Methods are a relatively new class of algorithms for pattern analysis in
data sets. The idea behind kernel methods is to have a systematic methodology
for incorporating nonlinearities into the predictor function [10]. In this section, we
will next describe the theory behind kernel methods.
Kernels
Kernel-based learning algorithms work by embedding the data into a Hilbert space,
often called the feature space, followed by a search for linear relations within this
Hilbert space. Kernels are functions that can be used to formulate similarity com-
parisons. They provide a general framework to represent data, subject to certain
mathematical conditions. Data are not represented individually by kernels. Instead,
data relations are represented through a set of pair-wise comparisons.
More formally, suppose we have n training data pairs ((x1, y1), · · · , (xn, yn)) ∈
X × Y where X is the input space, and Y is vector of the output values. In the
process of machine learning, we want to be able to generalize to previously unseen
data points. In the case of binary classification, given some new input x ∈ X, we
want to predict the corresponding y ∈ {+1,−1}. In other words, we want to choose
y such that (x, y) is in some sense similar to the training examples. In order to
achieve this, we require similarity measures in X and in Y . Since y ∈ {+1,−1} , to
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find the similarity measure in Y is relatively easy. On the other hand, we require
a function to measure the similarity in X:
k : X ×X → R,
(x, xi)→ k(x, xi)
(2.2.1)
satisfying, for all x, xi ∈ X : i = 1 .. n,
k(x, xi) = 〈φ(x), φ(xi)〉 , (2.2.2)
where φ maps points into a dot product space FS, called the feature space. The
similarity measure k is called a kernel, and φ is its feature map. Figure 2.2.2
illustrates the overall mapping concept.
Figure 2.2.2: The implicit function φ maps points in the input space over to the
feature space.
By using a kernel function, the embedding in the Hilbert space is actually per-
formed implicitly, that is by specifying the inner product between each pair of
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points rather than by giving their coordinates explicitly. This approach has several
advantages, the most important being the fact that often the inner product in the
embedding space can be computed much more easily using a kernel rather than
using the coordinates of the image points themselves.
In machine learning, using kernels is a strategy for converting a linear classifier
algorithm into a non-linear one by using a non-linear function to map the original
observations into a higher-dimensional feature space; this makes a linear classifica-
tion in the new feature space equivalent to a non-linear classification in the original
input space.
We also consider the matrix K with elements Kij = k(xi, xj), called the kernel
matrix or the Gram matrix . Because of the fact that it is built from inner products,
it is always a symmetric positive semi-definite matrix, and since it specifies the inner
products between all pairs of points, it completely determines the relative positions
between those points in the embedding space. According to Mercer’s theorem [89],
every symmetric, positive semi-definite bilinear function can be represented as an
inner product in a feature space. This property allows one to develop feature space
algorithms by simply using positive semi-definite kernel functions. Thus the exact
form of the feature images φ(x) does not have to be known.
Understanding the feature space FS and the norm associated with a kernel
often helps in understanding kernel methods and in designing new kernels.
Let k be a kernel on a space X. Let us assume that the prediction function
sought by kernel-based algorithms is a linear function in the feature space:
f(x) = 〈w, φ(x)〉 , (2.2.3)
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for some vector w ∈ FS. The w is called the weight vector and can be expressed






where the vector α, containing these αi as its entries, will be referred to as the dual
vector. With equation (2.2.4), we can express f as follows:





















In the remaining section, we will use f(.) to denote a function. Note that this is
different from f(x) which is f(.) evaluated at x. The space is a vector space and it
contains any linear combination of these functions. We will ensure that the space
also contains functions such as k(xi, .).
More formally, we start with a real-valued symmetric postive semi-definite ker-
nel:
k : X ×X → R. (2.2.7)
Our φ map takes points in X and maps them into a space of functions where each
function maps X into R. This space of functions is defined as:
R
X := {f |X → R}, (2.2.8)
and the kernel mapping is defined via:
φ : X → RX
x → k(x, .). (2.2.9)
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Another way to express this:
φ(x)(.) = k(x, .). (2.2.10)
One may think of RX as a very large space. Within RX , we focus on a smaller
infinite subset that is an inner product space derived from our given kernel function.
Our inner product space contains the functions k(xi, .) for all xi ∈ X. As a vector






where the xi are arbitary points in X and all αi ∈ R. Since FS is a Hilbert
space, a dot product can be defined for two elements f(.) =
∑n
i=1 αik(xi, .) and
g(.) =
∑m









We should think of this inner product as 〈f(.), g(.)〉.
One important property of this construction is that the value of f(x) of a func-
tion f ∈ FS can be expressed as a dot product in FS: f(x) = 〈f, k(x, .)〉 . By
taking g(.) = k(z, .), we have




αik(xi, z) = f(z). (2.2.13)
We rewrite equation (2.2.13) as
f(x) = 〈f, k(x, .)〉 . (2.2.14)
Equation (2.2.14) says that we can get the value of f(.) at x by evaluating the
inner product of two functions namely f itself and the function k(x, .). We say that
k is the representer of evaluation.
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Note that f(.) is any function in our vector space. We can set f(.) = k(z, .) in
f(x) = 〈f, k(x, .)〉, then we can derive the following reproducing property valid for
any x, z ∈ X:
〈k(z, .), k(x, .)〉 = k(z, x). (2.2.15)
For this reason, the feature space FS is usually called the reproducing kernel Hilbert
space (RKHS) assoicated with k. The equation (2.2.13) leads to the following
Theorem:
Theorem 2.2.1. For any kernel k on a space X, there exists a Hilbert space FS
and a mapping φ : X → FS such that
k(x, z) = 〈φ(x), φ(z)〉 , (2.2.16)
for x, z ∈ X. Given two points u, v ∈ FS, 〈u, v〉 represents the dot product in the
Hilbert space.
For more details about RKHS, readers can refer to [89].
By using a kernel, we have the following advantages:
1. Representation independently: The kernel matrix does not depend on
the nature of the objects to be analyzed. They can be images, molecules, or
sequences, and the representation of a data set is always a real-valued square
matrix. This independence enables one to develop more flexible algorithms
for different studies.
2. Complexity: The size of the matrix does not grow as the dimension of the
input data increases.
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3. Easy comparison: Kernels can act as a tool to measure similarity.
There are several common kernels. They include:
1. linear kernel: k(x, xi) = x
T xi, the inner product between vectors;
2. Gaussian kernel: k(x, xi) = e
−||x−xi||2/2σ; and
3. polynomial kernel: k(x, xi) = (〈x, xi〉+ c)d where d is the polynomial degree.
There are some other kernels defined in the reasearch literature for different pur-
poses. They include: string kernels [89], and tree kernels [89].
Kernel methods are a class of algorithm for which the data to be analyzed only
enter the algorithm through the kernel function. Common kernel methods include
the support vector machines (SVM).
Support Vector Machine
The Support Vector Machine (SVM) algorithm [89] is relatively new supervised
learning technique originally introduced by Vapnik [104]. The SVM has been suc-
cessively extended by a number of other researchers. In a classification problem,
the SVM separates a given set of binary labeled training data with a hyper-plane
that is maximally distant from them. This hyper-plane is called the maximal mar-
gin hyper-plane (Figure 2.2.3). The weight vector w and threshold b for the hard
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subject to:
yi(〈w, φ(xi)〉 − b) > 1, i = 1, · · · , n, (2.2.18)





















yiαi = 0 and 0 6 αi for i = 1, ..., n, (2.2.20)
where αi is the dual variable, and k(xi, xj) can be obtained from the kernel matrix
K. In practice, the data may not be separable in this fashion. By introducing slack














yi(〈w, φ(xi)〉 − b) > 1− ζi, i = 1, · · · , n, (2.2.22)
where the parameter C controls the trade-off between the width of the margin and
the size of the slack variables.
By using equation (2.2.21), we allow some negative samples inside the positive
side of the maximal margin hyper-plane and some positive samples outside the





















αi = 1 and 0 6 αi 6 C, for i = 1, ..., n. (2.2.24)
For more details about SVM, readers can refer to [89].
SVM have remarkable robust performance with respect to sparse and noisy data.
This makes SVM the strategy of choice in a number of applications ranging from
text categorization to protein function prediction.
Figure 2.2.3: An example of the Support Vector Machine.
Support Vector Regression
To perform regression, we made use of a linear ε-insensitive Support Vector Re-
gression (SVR). In ε-insensitive SVR, the goal is to find a function f(d) that has
at most ε deviation from the activity values of the training data. Suppose we are
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working with n training data samples. We apply the mapping indicated in equation
(2.2.9) repeatedly to generate φ(x1), φ(x2), · · · , φ(xn) . The weight vector w and















(〈w, φ(xi)〉+ b)− yi 6 ε + ξi
yi − (〈w, φ(xi)〉+ b) 6 ε + ξ̂i










i = 1, ..., n. (2.2.26)
where yi is the target value for data xi, ξ̂i and ξi are the slack variables representing
upper and lower constraints on the outputs of the regression system, and C is
a constant. The constant C > 0 determines the trade off between flatness of
the regression line and the amount up to which deviations larger than ε > 0 are

























(α̂i − αi) = 0 and 0 6 αi, α̂i 6 C, for i = 1, ..., n. (2.2.28)
where α̂i and αi are the dual variables corresponding to ξ̂i and ξi, and k(xi, xj) can
be obtained from the kernel matrix K. After making the substitution βi =
⌢
αi − αi


























βi = 0. (2.2.30)
After we find β∗ as a solution of the above optimization problem, we set up the




β∗j k(xj , x) + b




β∗j k(xj , xi)
for i with 0 < β∗i < C. For more details about SVR, readers can refer to Smola et
al. [91].
Kernel Methods in Computational Biology
More recently, kernel methods have been widely used in computational biology.
Support Vector Machines (SVM) have been found to be very useful in this area.
They offer versatile tools to process and analyze data and can offer state-of-art
performance under different situations [87]. Common applications include:
1. protein remote homology detection;
2. receptor classification and protein function annotation;
3. microarray gene expression analysis;
4. proteomics/protein expression analysis.
The use of kernel methods in computational biology is advisable for the following
reasons:
1. The biological data are usually contained in high dimensional spaces.
2. The data are complicated by noise.
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3. Kernel methods can handle the variable length data that is often seen in
biological applications.
Kernel Methods in QSAR modeling
Currently, kernel methods are popular tools in QSAR modeling and are used to
predict attributes such as: activity towards a therapeutic target, ADMET proper-
ties (absorption, distribution, metabolism, excretion, and toxic effects), and adverse
drug reactions. Various kernel methods based on different molecular representations
have been proposed for QSAR modeling [4], they include the SMILES strings kernel
[100], graph kernels [28, 72, 80] and a pharmacophore kernel [71].
Chapter 3
The Vector Space Model
Molecular Descriptor
The manipulation and analysis of chemical structural information of a ligand is
made possible through the use of a molecular descriptor. A good molecular descrip-
tor should not only be able to capture important molecular properties, it should
also be able to facilitate the derivation of computational model. An ideal computa-
tional model should predict ligand binding affinities based on molecular descriptors
in a nonlinear fashion. It should also be able to handle an imbalanced and noisy
data set.
In this chapter, we propose a vector space model molecular descriptor (VSMMD)
based on a vector space model that is suitable for kernel studies in QSAR modeling.
36
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3.1 The vector space model molecular descriptor
Our vector space model molecular descriptor (VSMMD) would be categorized as
belonging to the constitutional descriptors that provide component counts related
to the structure of a molecule. Similar to other fragment based methods, the topo-
logical patterns of atoms and bonds in a molecule are encoded into our descriptor.
Fragment based methods like HQSAR [69] and ECFP [83] have been used with
considerable success in various QSAR studies [30, 43]. Among different kinds of
fragment based methods, HQSAR and ECFP provide better performance among
others [30, 43]. However, when dealing with a small data set (< 500 data points),
both methods often overfit to the training set and lead to poor performance on the
test set [30]. Our VSMMD approach is designed to address this issue.
The first step in constructing the VSMMD is to identify the physicochemical
properties of each atom in a molecule. Specifically, we affix labels to atoms and
bonds as specified in Figure 3.1.1. It should be noted that triple bonds would also
be labeled as “=”.
The VSMMD strategy is based on the extraction of molecular fragments that
are comprised of bonded atoms. The atom count for a fragment is at least two and
at most fa where fa is some pre-specified relatively small value such as 2, 3, or 4.
To illustrate the processing of a molecule we describe the steps that are taken
in the processing of a molecule (atom count for a fragment limited to 2). Figure
3.1.2 shows one of the pyrrole compounds that is a member of the data set used
in [96]. The algorithm goes through the following steps:
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Figure 3.1.1: Labels for atoms and bonds in a molecule
1. The atoms and bonds are labeled using the 7 atom types and 3 bond types
as prescribed by Figure 3.1.1.
2. The molecular descriptor is created by extracting from the molecule a com-
plete set of small fragments.
3. Frequency counts are evaluated for all the fragments so that a multi-set or
bag can be generated.
When these steps are completed, the multi-set counts are placed into a vector
that has a position for each of the different possible fragments. For example, if
fragment size is limited to 2 atoms this vector would have a dimensionality of
7*7*3 = 147.
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Figure 3.1.2: Processing steps for the VSMMD.
3.2 VSM and VSMMD compared
The motivation for the VSMMD descriptor comes from the “bag-of-words” ap-
proach [89] that is based on the vector space model (VSM). Roughly speaking, the
atom fragments, extracted in the VSMMD process, correspond to the document
words and phrases extracted in the VSM. The molecular descriptor is then anal-
ogous to the text document and much of the analysis used in the bag-of-words
strategy can be brought over to the VSMMD setting.
In practice, we have found that the success of VSMMD is greatly enhanced by
utilizing fragments that contain at least two atoms, for example, fa = 2 or fa = 3.
This adoption of a higher level of structure corresponds to the incorporation of
phrase structures in the VSM. As the value of fa increases there is a point of
diminished returns due to the combinatorial explosion of fragment possibilities. To
help reduce this “curse of dimensionality”, we can remove the vector entries that
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Type ID General Fragment Type Atom Count(fa)
1) AT BT AT 2
2) AT BT AT BT AT 3
3) AT BT AT BT AT BT AT 4
4) AT BT AT BT AT 4
BT
AT
Table 3.2.1: General format of the fragment dictionary (AT =Atom Type, BT =Bond
Type)
have been observed to have frequency counts equal to zero across all molecules
under consideration.
In the VSM, a language dictionary can be defined using some permanent prede-
fined set of words. In our model, according to the encoding scheme, the dictionary
will be the collection of all possible atom type (AT ) and bond type (BT ) labeled
graphs that arise from molecular fragments that are restricted to having atom
counts of 2, 3, or 4. Table 3.2.1 shows the general format of our dictionary with fa
limited to 4. The last entry of this table represents a four atom fragment in which
a central atom is bonded to three other atoms.
In the most general case, a molecular descriptor is represented by a bag of
fragments, each an entry in the dictionary.
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3.3 Analysis based on VSMMD
We now describe the notation and mathematical setting used in VSMMD. After
the molecular descriptor d is generated, we represent the descriptor as a column
vector in an m dimensional space using the mapping
φ : d 7→ φ(d) = (q(f1, d), q(f2, d), · · · , q(fm, d))T ∈ Rm (3.3.1)
where q(fi, d) is the frequency of the fragment fi in the descriptor d.
The use of φ (.) in this last equation is deliberate since we want to view this
mapping as the type of kernel function that is used in the bag-of-words strategy
described by Shawe-Taylor and Cristianini [89]. Via this mapping, each molecular
descriptor is taken over to an m-dimensional vector, where m is the size of the
dictionary. Although m could be very large, the typical vector generated in this
way is usually quite sparse (just as vectors in the VSM are sparse).
Working with n molecules, we can apply the mapping repeatedly to generate a
succession of column vectors: φ(d1), φ(d2), · · · , φ(dn). Computation of the vector
space kernel is done by calculating the fragment-descriptor matrix F with rows
indexed by the fragments and columns indexed by the descriptors:
F =
(



















The entry at position (i, j) gives the frequency of fragment fi in document dj.
Subsequently, we create the kernel matrix as
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K = F T F (3.3.3)
corresponding to the vector space kernel




q(fz, di), q(fz, dj). (3.3.4)
With the vector space kernel, we can apply a kernel-based method to generate a
predictor of any one of several biological activities, for example: affinity of ligands
used as therapeutic agents or ADMET properties. To reduce the row dimensions
of the F matrix, it is possible to employ component selection procedures that
attempt to eliminate fragment entries that appear to have little or no influence on
the prediction algorithm being developed.
3.4 Data Fusion for VSMMD
The VSMMD strategy is based on the extraction of molecular fragments that are
comprised of chains of bonded atoms. Consequently, different fragment lengths
will give different results. In this section, we give a useful strategy to combine
different kernel matrices by computing a weighted average of all kernel matri-
ces generated by different fragment lengths. Suppose we have p kernel matrices
K1, K2, ..., Kp. We can compute the average of all kernels normalized by positive
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Note that the choice of βj may be arbitrary, as long as they are positive. How-
ever, a recent study [19] gave theoretical evidence that βj should be proportional
to the trace of Kj divided by the original dimension of the data.
Suppose we want to study four different fragment types as shown in Table
3.2.1. By using equation (3.3.3), we can create four different kernel matrices
K1, K2, K3, K4 corresponding to each fragment type. To perform data fusion of
these four kernel matrices, we use equation (3.4.5) with p = 4 and βj is the trace
of Kj divided by the total number of different descriptors for that type j fragment.
3.5 Experimental Results
3.5.1 Data
In our QSAR study, eight different data sets were used to test the ability of the
VSMMD to predict biological activities. All these data sets contain real valued
QSAR inhibitor data.
The eight QSAR data sets are from Sutherland et al. [96]. The first data set
contains 114 angiotensin converting enzyme (ACE) inhibitors collected by Depriest
and colleagues [20] with pIC50 values ranging from 2.1 to 9.9. pIC50 is a measure of
the effectiveness of a compound in inhibiting biological function. The second data
set contains 111 acetylcholinesterase (AchE) inhibitors assembled by Sugimoto et
al. [94] and split into training and test data sets by Golbraikh et al. [32] with
pIC50 values ranging from 4.3 to 9.5. The third data set contains 163 ligands for
the benzodiazepine receptor (BZR) assembled from the work of Haefely [37] and his
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colleagues and reported by Maddalena et al. [70] with pIC50 values ranging from
5.5 to 8.9. The fourth data set contains 322 cyclooxygenase-2 (COX2) inhibitors
collected by Seibert and colleagues [46] and subsequently utilized in a QSAR study
by Chavatte et al. [12] with each inhibitor having pIC50 values ranging from 5.5
to 8.9. The fifth data set contains 397 dihydrofolate reductase inhibitors (DHFR)
collected by Queener and colleagues [9] and set up as data sets by Sutherland and
Weaver [97] with each inhibitor having pIC50 values for rat liver enzyme ranging
from 3.3 to 9.8. The final three data sets were prepared by Klebe and his col-
leagues [8, 31, 60]. They include 66 inhibitors of glycogen phosphorylase b (GPb)
with pKi values ranging from 1.3 to 6.8, 76 thermolysin inhibitors (THER) having
pKi values ranging from 0.5 to 10.2 and 88 thrombin inhibitors (THR) with pKi
values ranging from 4.4 to 8.5.
In all our experiments the data were separated into the same training and testing
sets used by Sutherland et al. [96]. Leave-one-out cross validation was used to
obtain the best parameters for model generation.
3.5.2 Implementation details
To identify the physicochemical properties of each atom, we implemented our de-
scriptor generation program using the chemical development kit (CDK) [92, 93]
programmed in Java. As illustrated in Figure 3.1.2, we traversed each molecule
once and the kernel matrix K was generated in a few seconds for each complete
data set.
For classification, we used SVMlight [48] to perform the support vector regres-
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sion experiments.
3.5.3 QSAR results
To perform regression, we made use of a linear ε-insensitive Support Vector Regres-
sion (SVR) algorithm as mentioned in the previous chapter. In our experiments, ε
was set to 0.1, and the Gaussian kernel [89]
k(di, dj) = e
−〈φ(di),φ(dj)〉/2σ2 , (3.5.6)
was used for the SVR. Two parameters, σ and C, had to be evaluated through
cross-validation. A simple grid search was used to select the parameters σ and
C. In the grid search, we considered only the Gaussian kernels with parameter σ
equal to values ranging from 1 to 60 in steps of 1. The parameter C was chosen
from values ranging from 100 to 1000 in steps of 100. For all eight data sets, we
obtained the best σ and C by leave-one-out cross validation using only the training
set. Table 3.5.2 gives the value of σ for all eight data sets across various descriptor
models.
The prediction accuracy was assessed using the designated test sets and sub-
sequently residual r2 statistics [42] were obtained. A residual r2 value close to
one indicates a better prediction. The residuals, for all the eight data sets, across
various descriptor models are given in Table 3.5.3.
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TypeID ACE AchE BZR COX2 DHFR GPB THER THR
1 1 5 6 35 9 1 3 3
2 2 2 35 15 2 8 5 5
3 1 1 15 2 20 2 1 1
4 2 1 35 2 10 1 60 60
1 ∪ 2 1 1 35 10 1 7 2 2
1 ∪ 2 ∪ 3 1 1 15 10 6 2 1 1
1 ∪ 2 ∪ 3 ∪ 4 3 2 15 2 3 1 1 1
Table 3.5.2: σ values derived using cross-validation. TypeID is the fragment type
ID defined in Table 3.2.1
3.6 Discussion
For the eight data sets, Sutherland et al. [96] tried 7 different descriptor sets.
They include CoMFA [16], CoMSIA basic [60], CoMSIA Extra [59], EVA [26],
HQSAR [69], Cerius2 2D and Cerius2 2.5D. Of these descriptor sets, only the
Cerius2 2.5D set was available for experimental comparison. Their experiments
show that none of these descriptor sets can completely outperform the others. For
a detailed description of the Cerius2 2.5D descriptor, the reader may consult Suther-
land et al. [96].
To compare our VSMMD results with those of Sutherland et al., we worked
with the given Cerius2 2.5D descriptors and then performed a regression using
SVR. In order to provide a fair comparison, full cross-validation studies were run
on both VSMMD and Cerius2 2.5D descriptors. For Cerius2 2.5D, we performed
leave-one-out cross validation on the training set only to obtain the optimal value
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TypeID ACE AchE BZR COX2 DHFR GPb THER THR
1 0.45 0.48 0.32 0.35 0.53 0.23 0.39 0.16
2 0.39 0.5 0.38 0.31 0.5 0.76 0.33 0.24
3 0.4 0.35 0.31 0.31 0.59 0.56 0.29 0.05
4 0.39 0.35 0.23 0.26 0.57 0.26 0.28 0.14
1 ∪ 2 0.4 0.48 0.38 0.34 0.5 0.73 0.35 0.24
1 ∪ 2 ∪ 3 0.42 0.36 0.38 0.32 0.57 0.55 0.38 0.25
1 ∪ 2 ∪ 3 ∪ 4 0.4 0.22 0.35 0.41 0.61 0.25 0.36 0.29
Table 3.5.3: r2 statistics using SVR on the testing set
for the two parameters C and σ. For the VSMMD, we performed leave-one-out
cross validation on the training set only to obtain the optimal value for the three
parameters C, σ and the fragment type ID as defined in Table 3.2.1. Table 3.6.4
summarizes the comparison between our results and those of Sutherland et al. Both
residual r2 statistics and the cross-validated residual statistics q2 are shown.
In Table 3.6.4, it can be seen that by using our VSMMD descriptor, we obtained
a higher residual r2 indicating that our descriptor set performs significantly better
than the Cerius2 2.5D descriptor in five out of eight data sets. As mentioned in
Sutherland et al., Cerius2 2.5D descriptors perform reasonably well on these two
data sets and so these empirical results indicate that the VSMMD descriptor set is
very suitable for kernel models.
Sutherland et al. also utilized various model-building methods, including Partial
Least Squares (PLS) [112], methods related to Genetic Algorithms [84, 21], and
neural networks [78, 56]. Table 3.6.5 summarizes the comparison between our
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ACE Ache BZR COX2 DHFR GPb THER THR
r2 0.45 0.31 0.21 0.32 0.51 0.26 0.39 0.3
Cerius2 q2 0.66 0.15 0.15 0.56 0.53 0.35 0.7 0.35
std(q2) 0.3539 0.2542 0.286 0.2355 0.3969 0.2299 0.3798 0.2638
r2 0.39 0.48 0.32 0.41 0.57 0.76 0.38 0.29
VSMMD q2 0.74 0.23 0.41 0.42 0.6 0.57 0.31 0.22
std(q2) 0.0535 0.1673 0.3603 0.3508 0.062 0.29 0.1565 0.1601
Table 3.6.4: Comparison of the residual statistics r2 comparing the VSMMD de-
scriptor set and the Cerius2 2.5D descriptor set (both using SVR)
results and the best results reported by Sutherland et al.
Table 3.6.5 gives evidence that by using the VSMMD descriptor, we obtained a
higher residual r2 in four out of eight data sets and performed robustly across all
eight data sets.
We also compared the VSMMD kernel with the 2D graph spectrum kernel [72]
and the 3D pharmacophore kernel [71] based on a regression using SVR utilizing
the same data set. For the 2D graph spectrum kernel, we performed 10-fold cross
validation, on the training set only, to obtain the optimal value for the three pa-
rameters C, σ, and the fragment length. For the 3D pharmacophore kernel, we
performed 10-fold cross validation, on the training set only, to obtain the optimal
value for the two parameters C and σ. For the VSMMD, we performed leave-one-
out cross validation on the training set only to obtain the optimal value for the
three parameters C, σ and the fragment type ID as defined in Table 3.2.1. Table
3.6.6 summarizes the comparison of our kernel results with others.
Table 3.6.6 gives evidence that by using the VSMMD kernel, we obtained a
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ACE AchE BZR COX2 DHFR GPb THER THR
VSMMD 0.39 0.48 0.32 0.41 0.57 0.76 0.38 0.29
Cerius 2.5D 0.51 0.16 0.20 0.27 0.49 0.04 0.07 0.28
CoMFA 0.49 0.47 0.00 0.29 0.59 0.42 0.54 0.63
CoMSIA 0.52 0.44 0.08 0.03 0.52 0.46 0.36 0.55
EVA 0.36 0.28 0.16 0.17 0.57 0.49 0.36 0.11
HQSAR 0.30 0.37 0.17 0.27 0.63 0.58 0.53 -0.25
Table 3.6.5: Comparison of the residual statistics r2 comparing the VSMMD de-
scriptor set using SVR and the various descriptor sets reported by Sutherland et
al. using PLS
higher residual r2 in seven out of eight data sets. Furthermore, the computational
time for the VSMMD kernel is much faster than the 3D pharmacophore kernel.
In order to investigate whether our descriptors have the ability to capture the
important properties of a molecule, we performed a more detailed analysis of the
COX-2 data set. Reviewing the data set, we considered the molecules that had the
top 10 highest activity values. For each molecule, we obtained the five descriptors
with the highest rank using inverse document frequency [89]. These ten molecules,
together with the location of the highest ranked descriptor (circled in red) are
displayed in Figure 3.6.3. Among the ten molecules, the cyclopentene ring was the
highest ranked descriptor in seven of the high affinity molecules. From medicinal
chemistry studies, we know that cyclopentene derivatives are one of the first series of
diaryl-substituted cycles successfully investigated as COX-2 inhibitors [66, 82]. This
empirical evidence demonstrates that our descriptors are able to specify important
properties of the molecule.
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Figure 3.6.3: Location of highly ranked descriptor (circled) in selected COX-2
molecules.
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ACE AchE BZR COX2 DHFR GPb THER THR
2D r2 0.2 0.06 0.11 0.27 0.48 0.07 0.16 0.19
Graph q2 0.4 0.06 0.31 0.44 0.53 0.21 0.12 0.16
std(q2) 0.017 0.026 0.093 0.092 0.148 0.074 0.06 0.08
3D r2 0.39 0.36 0.3 0.32 0.63 0.48 0.28 NA*
pharma- q2 0.69 0.276 0.42 0.47 0.66 0.48 0.16 NA*
cophore std(q2) 0.056 0.119 0.046 0.134 0.057 0.191 0.09 NA*
r2 0.39 0.48 0.32 0.41 0.57 0.76 0.38 0.29
VSMMD q2 0.74 0.23 0.41 0.42 0.6 0.57 0.31 0.22
std(q2) 0.0535 0.1673 0.3603 0.3508 0.062 0.29 0.1565 0.1601
Table 3.6.6: Comparison of the residual statistics r2 comparing the VSMMD with
the graph kernel and the pharmacophore kernel (all using SVR) (*supplied program
failed to provide results)
3.7 Conclusion
In this chapter, we have introduced a constitutional descriptor, the vector space
model molecular descriptor (VSMMD) that is similar to the vector space model
used by researchers in information retrieval. The significance of this model rests
on its mathematical setting. Molecular descriptors are converted to vectors that
represent the molecules as points in a descriptor input space. Using kernel method
strategies these points can be mapped into a feature space that is suitable for various
machine learning techniques such as classification by support vector machines or
regression by support vector regression algorithms.
Furthermore, since the VSMMD descriptor is directly based on molecular frag-
ments, it is possible to use a ranking procedure to determine those fragments that
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are most important in the prediction of high affinity molecules. This interpretabil-
ity is very important in drug design efforts since it gives valuable information about
the structure of high affinity drug candidates leading to a more focused search in
high-throughput screening exercises.
Based on these encouraging empirical results, we are confident that this vector
space modeling of molecular descriptors has the potential to provide a versatile
mathematical setting for further developments in this area.
Chapter 4
Component Selection
High dimensionality of descriptors poses a challenge for statistical learning algo-
rithms to formulate predictors. The minimum number of samples required to ensure
a high level of prediction confidence rapidly increases as the dimensionality of the
descriptors increases. We need computational strategies to do component selection,
keeping only those components in the initial version of a molecular descriptor that
are useful for later study.
In this chapter, we present a new component selection algorithm KACS (Kernel
Alignment Component Selection) based on kernel alignment for QSAR studies.
4.1 Introduction
Component selection, sometimes called “feature section” is an essential data pre-
processing step that is needed in machine learning, wherein a subset of the descrip-
tor components is selected for participation in a learning algorithm. The idea of
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component selection is to remove irrelevant or redundant components from a set of
computed components contained in the initial version of a descriptor. The final ob-
jective is to utilize these improved descriptors as training data in the construction
of a good predictor or classifier for particular machine learning problems. With a
good selection of components, the following benefits can be achieved:
1. improving the prediction accuracy of the predictor,
2. reducing computational time and storage requirements, and
3. providing a better understanding and clear interpretation of the underlying
process that generated the data.
In many modern scientific research studies, component selection is an indispens-
able step of data analysis. In general, a subset of components is chosen based on
the following two criteria:
1. find a subset of the available components that gives the smallest expected
generalization error; or
2. find a smallest subset of the available components that is below some pre-
specified maximum allowable generalization error.
In this chapter, our research studies mainly focus on selecting a subset of com-
ponents that is subject to the first criterion. That is, our objective is to select a
subset of components that minimizes the expected error.
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Currently, many methods have been developed for component selection. In
general, there are three main approaches: filter methods, wrapper methods, and
embedded methods. We will review these three approaches in the following section.
4.1.1 Filter Methods
Filter methods usually select subsets of components as a pre-processing step, using
an approach that is independent of the classifier’s objectives. In other words, the
components are selected with regard to some predefined relevance measure that is
independent of classifier performance. Common measures include the correlation
index and mutual information.
For example, Pearson’s correlation coefficient is commonly used to eliminate re-
dundant components. It is a statistical method used to measure the linear relation-
ship between two variables. The correlation is also commonly used in conjunction
with principle component analysis [108] to rank the importance of the components.














where x and y are two random variables, x̄ and ȳ are their corresponding means.
Mutual information, sometimes called information gain, is also widely used in
QSAR applications [107]. The information of the component is defined in terms
of entropy of the component treated as a random variable.
The mutual information of two discrete random variables X and Y can be
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defined by:











where p(x, y) is the joint probability distribution function of X and Y , while p1(x)
and p2(y) are the marginal probability distribution functions of X and Y respec-
tively.
Based on this notion, various measures relating the information shared between
two components or between a component and its related activity can be defined.
These strategies are commonly used in QSAR studies to rank the components.
4.1.2 Wrapper Methods
Wrapper methods utilize some particular learning machine as a black box to score
subsets of variables according to their predictive power [35]. Some common models
include simulated annealing, genetic algorithms, and sequential forward/backward
elimination.
In Simulated Annealing (SA) [58], a function usually based on Boltzmann’s
distribution, is utilized to minimize the error of the model built using a subset
of components. The SA strategy usually starts from a random configuration of
subsets and then attempts to find a better subset of the components by altering
the subset currently considered to be the best. Next, SA evaluates the prediction
error of the new subset. If the new solution is better than the current best solution,
it will update the current best solution. If the new solution is slightly worse than
the current best solution, it might still be retained based on a comparison that
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involves the Boltzmann distribution. The iterative procedure continues until no
further enhancement can be found or until the stopping criteria is satisfied.
The genetic algorithm, similar to SA, relies on a guided random process to
explore the space of component subsets. Venkatraman et al. [107] provide a good
discussion on how a genetic algorithm can be applied to component selection.
In addition to the stochastic algorithms mentioned above, the sequential com-
ponent forward / backward selection (SCFS / SCBS) algorithm [114, 113]operates
in a deterministic manner. Both SCFS and SCBS use a greedy approach to search
the component subsets. For SCFS, we begin with one component that leads to the
best prediction, then each component is individually added to the current subset
and the errors of the resulting models are quantified. The component that is the
best in reducing the error is incorporated into the subset. We repeat the process
until some stopping criteria has been achieved. For SCBS, we begin with the full
set of components, then each component is individually eliminated from the current
subset and the errors for the resulting models are quantified. The component that
leads to a model with the highest error is removed from the current subset. The
SCBS process is repeated until some stopping criterion has been met.
4.1.3 Other Methods
In addition to purely filter or wrapper-based component selection methods, some
methods utilize fusion of these two approaches. An example of this “embedded
method” involves the combining of the correlation index strategy with the greedy
algorithm [33].
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4.1.4 Component Selection for Computer-Aided
Drug Design
In the literature, over 1000 different descriptors have been proposed [102]. Selecting
appropriate descriptor components to represent a molecule is a critical and impor-
tant step. It has been shown in [87] that the quality of an inferred model strongly
depends on the selected components. Thus, component selection for computational
drug design remains a topic of high importance in the QSAR community.
Filter based component selection algorithms are becoming popular tools in
QSAR studies. Some examples:
1. Merkwirth et al. [75] created a cluster of components using the correlation
coefficient of candidate components and then retained only one representative
for each cluster;
2. Guha et al. [33] used a random forest model to provide an alternate measure
of the importance of a component;
3. Liu [67] used information gain to select components for different data sets;
and
4. Venkatraman et al. [107] combined a genetic algorithm with mutual infor-
mation to select components.
Among the entire wrapper based component selection algorithms, genetic algo-
rithms have been often used with a wide range of mapping methods. Examples
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include neural networks [33], nearest neighbor methods [6] and random forest
methods [33]. Simulated Annealing has also been used in component selection for
QSAR studies. For example, Sutter et al. [98] employed generalized simulated
annealing to select an optimal set of components. Variants of forward/backward
recursive component selection methods have been used in numerous QSAR stud-
ies. For example, Xue et al. applied both forward [114] and backward recursive
component selection [113] methods to different QSAR data sets.
4.2 Kernel Alignment Component Selection (KACS)
In this section, we present a new component selection algorithm KACS (Kernel
Alignment Component Selection) for a QSAR study based on kernel alignment
[17]. Kernel alignment has been developed as a measure of similarity between
two kernel functions. In our algorithm, we refine kernel alignment as an evaluation
tool, using recursive component elimination to eventually select the most important
components for classification. Theoretical and empirical analyses follow after the
algorithm is presented.
4.2.1 Kernel Alignment
Kernel alignment has been developed as a measure of similarity between two kernel
matrices [17]. Suppose we are working with a data space X containing n training
samples stored as column vectors: x1, x2, · · ·xn. Given kernel functions k1(x, y) and
k2(x, y) we can construct their corresponding Gram (or kernel) matrices K1 and
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K2 defined as {K1}ij = k1 (xi, xj) and {K2}ij = k2 (xi, xj) . The empirical
alignment of matrix K1 with matrix K2, with respect to the sample data X, is




〈K1, K1〉F 〈K2, K2〉F
, (4.2.3)
where 〈K1, K2〉F is the Frobenius inner product which measures the similarity be-








k1(xi, xj)k2(xi, xj). (4.2.4)
In the case of binary classification, for a given new input x ∈ X, we want to
predict the corresponding response y, where y = +1 or − 1. An “ideal” kernel
matrix can be formed by calculating:
Kideal = yy
T. (4.2.5)














where ‖K‖F is the Frobenius norm of the kernel matrix K.
Kernel alignment can be viewed as the cosine of the angle between two kernel
matrices K1 and K2 . It can also be considered as a Pearson correlation coefficient
between the random variables K1(x, z) and K2(x, z).
4.2.2 SVM based Recursive Component Elimination (RCE)
SVM based Recursive Component Elimination (SVM-RCE) is an iterative sequen-
tial backward component selection algorithm purposed by Guyon et al. [36] for
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gene selection using a support vector machine (SVM). Initially the SVM classifier
is trained with the full component set. The significance of a component is char-
acterized by the weight that the SVM optimization assigns to that component.
Guyon proposed using the weight magnitude from the SVM as a ranking criterion.
At each iteration step, the component with the smallest ranking criterion is elim-
inated. By doing so, the components that contribute least to the maximization of
the separation margin are removed. SVM-RCE is a wrapper based approach. At
each step, the SVM must be trained in order to obtain this ranking criterion. In
Guyon’s studies, a linear-SVM classifier was used.
Later, Yu et al. [116] modified the SVM-RCE algorithm by using a nonlinear
SVM classification system of polynomial kernels for prediction of drug activity. Xue
et al. [113] further extended the SVM-RCE strategy by using a nonlinear SVM
classification system with a Gaussian kernel.
4.2.3 Kernel Alignment Component Selection Algorithm
Instead of using a wrapper based approach, we propose a filter based component
selection algorithm using kernel alignment as a ranking criterion. In general, this
will be a faster computation.
To begin our approach, we recompute the kernel Kideal by centering the response
as follows:
Kideal = y
∗y∗T where y∗ = y − ȳ (4.2.7)
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where ȳ represents the mean of the y target values in the training set. We start
with a full set of components. Next, we recursively remove the component that
produced the maximum difference between the kernel alignment value evaluated
with the reduced component set and the kernel alignment value evaluated with
the current component set, that is, we remove the component that maximizes the
difference KA(Kremoved, Kideal) −KA(Kcurrent, Kideal). A valid stopping condition
can be formulated based on a combination of changes in the kernel alignment value
and changes in the leave-one-out error in each step. A reasonable stopping condition
would be:
• Stops the algorithm when KA(Kremoved, Kideal)−KA(Kcurrent, Kideal) < 0.
Consequently, we stopped with the component set that maximized the kernel align-
ment.
The following steps summarize our algorithm:
1 Kernel Alignment Component Selection Algorithm
2 Input: training set X, label set y, stopping condition sc.
3 Compute the kernel alignment value KA(Kcurrent, Kideal) for X;
4 for p = 1 to the number of components remaining in X
5 Compute the Kernel matrix Kremoved(p) with component p removed;
6 Compute the kernel alignment value KA(Kremoved(p), Kideal) ;
7 endfor
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8 Remove the component providing the maximum KA(Kremoved(p), Kideal) −
KA(Kcurrent, Kideal) ;
9 Update X;
10 Repeat step 3 to step 9 until some stopping condition sc has been met;
11 return X;
4.2.4 Theoretical Analysis
In the Kernel Alignment Component Selection Algorithm, for each iteration, we
removed the component that let the remaining components maximize
KA(Kremoved(p), Kideal)−KA(Kcurrent, Kideal). (4.2.8)
In this subsection, we will show that maximizing (4.2.8) will lower the generaliza-
tion error bound in an SVM classifier.
Suppose we have n training data pairs ((x1, y1), · · · , (xn, yn)) ∈ X×Y where X
is the input space and Y is the set of corresponding output values. In the case of
binary classification, xi ∈ Rm and yi ∈ {+1,−1} . Partition the training data into
two groups c+ and c− , where c+ contains the samples with output value y = +1
and c− contains the samples with output value y = −1 . We will use the analysis of
variance (ANOVA) technique to study the source of variation of the training data.




(xi − x̄+)(xi − x̄+)T +
∑
xi∈c−
(xi − x̄−)(xi − x̄−)T (4.2.9)
CHAPTER 4. Component Selection 64
where x̄+ and x̄− are the mean vectors for the groups c
+ and c−, respectively.
The between-classes sum of squares matrix SSB, is:
SSB = n+(x̄+ − x̄)(x̄+ − x̄)T + n−(x̄− − x̄)(x̄− − x̄)T (4.2.10)
where n+ and n− are the sample sizes of group c
+ and c− , respectively, and x̄ is
the mean vector for the entire training data set.




(xi − x̄)(xi − x̄)T +
∑
x∈c−
(xi − x̄)(xi − x̄)T = SSB + SSw (4.2.11)
By using a kernel function, k(xi, xj) = 〈φ(xi), φ(xj)〉 , we get the implicit defini-
tion of φ, where φ maps a sample point x into a feature space FS. The similarity
function k(., .) is called a kernel, and φ is called its implied mapping. The feature
space FS is also called the reproducing kernel Hilbert space (RKHS) associated








The norm may be used to calculate the length of the line joining two images φ(x1)
and φ(x2):
‖φ(xi)− φ(xj)‖2 = 〈φ(xi)− φ(xj), φ(xi)− φ(xj)〉
= 〈φ(xi), φ(xi)〉 − 2 〈φ(xi), φ(xj)〉+ 〈φ(xj), φ(xj)〉
= k(xi, xi)− 2k(xi, xj) + k(xj , xj).
(4.2.13)
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The analysis is similar to that just described for the input space. In the feature




(φ(xi)− x̄φ+)(φ(xi)− x̄φ+)T +
∑
xi∈c−
(φ(xi)− x̄φ−)(φ(xi)− x̄φ−)T (4.2.15)
where x̄φ+ and x̄
φ
− are the respective mean vectors for the images of classes c
+ and
c− in the feature space. The between-classes sum of squares matrix SSφB, is:
SSφB = n+(x̄
φ
+ − x̄φ)(x̄φ+ − x̄φ)T + n−(x̄φ− − x̄φ)(x̄φ− − x̄φ)T (4.2.16)










= SSφB + SS
φ
w (4.2.17)
Since the feature space can have arbitrary high dimensions, the matrices SSφw ,
SSφB and SS
φ
T are almost always singular [109] and cannot be explicitly computed
in terms of the kernel matrix [77]. In order to express the sum of squares matrices
in terms of kernel matrix, we utilize the following identities:
Identity 4.2.1. The trace of the between-classes sum of squares matrix SSφB is
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Proof.





































































Now, we will show that the kernel alignment value KA(K, Kideal) has a partic-
ular relationship with trace(SSφB) and trace(SS
φ
T ):







Proof. In order to prove this inequality , we first must prove the following two
lemmas:
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Without loss of generality, let us assume that the first n+ data samples belong
to class c+ and the remaining n− data samples belong to c
−.









for i = 1, · · ·n+
−1− n+−n−
n
for i = n+ + 1, · · ·n.
(4.2.22)
the corresponding ideal kernel matrix is Kideal = y































if (xi ∈ c+ and xj ∈ c−) or (xi ∈ c− and xj ∈ c+.)
(4.2.23)
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Proof. For a Gaussian RBF kernel, the kernel matrix K will be normalized such
that all the elements in the matrix satisfy 0 < k(xi,xj) 6 1 . Under this kernel, the
images of all points have norm 1 in the resulting feature space since k(xi,xi) = 1.
Consequently, the feature space distance between two points is:
‖φ(xi)− φ(xj)‖2 = 〈φ(xi)− φ(xj), φ(xi)− φ(xj)〉
= 〈φ(xi), φ(xi)〉 − 2 〈φ(xi), φ(xj)〉+ 〈φ(xj), φ(xj)〉 .
(4.2.26)

























CHAPTER 4. Component Selection 72

































































































































= n2 − n trace(SSφT )
(4.2.29)
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n2 − n trace(SSφT )
.
So the corollary is proven.
Theorem 4.2.7. In an SVM classifier, the upper bound of the generalization error
can be reduced by maximizing the kernel alignment value KA(K, Kideal).
Proof. The upper bound of an estimate of the leave-one-out (LOO) generalization





where R is the radius of the smallest hypersphere enclosing the training samples
in the feature space FS and γ is the separation margin. Consider a hard margin


























y∗i αi = 0 and αi > 0
(4.2.32)





1/n+ if xi ∈ c+
1/n− if xi ∈ c−
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Since γ = 1
‖W (α∗)‖










Now, consider the problem of finding the smallest hypersphere that encloses the
training data [68]. Suppose α∗ is the optimal solution for the following dual
problem:













αi = 1 and αi > 0
(4.2.36)























































The radius, R, of the smallest hypershphere enclosing the training samples in the
feature space FS is:
R2 = W (α∗) (4.2.38)
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From (4.2.31), we notice that 4R
2
γ2
is the upper bound of Errorloo for R
2 and γ2













, we minimize R2 and maximize γ2. Consider (4.2.39), the mini-













































































Now, R2 and γ2 are always non-negative for a kernel which maps the input data
onto a unit hypersphere. Thus, n − 〈K,K〉F
n
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always non-negative. So, for a fixed 〈K, K〉F , increasing the KA(K, Kideal) results
in lowering the upper bound of the Errorloo.
For each iteration in the Kernel Alignment Component Selection Algorithm,
we removed the component that gives the maximum KA(Kremoved(p), Kideal) −
KA(Kcurrent, Kideal) . In other words, among all the reduced component sets, we
kept the subset that maximizes the kernel alignment value. This reduced set will
replace the current set for the next iteration. According to Theorem 4.2.7, the
operation will produce a lower error bound.
4.2.5 Empirical Analysis
The purpose of this subsection is to study the effect of kernel alignment on the
generalization error.
The experiments use 4 data sets from the UCI repository. Table 4.2.1 gives a
brief summary on the UCI data set.
Data Set Train size (n) Components (m) Classes
Breast Cancer 699 9 2
Sonar 208 60 2
German Credit 1000 24 2
Votes 435 16 2
Table 4.2.1: UCI data sets
For each data set, the components were normalized. The Kernel Alignment
Component Selection Algorithm was run using the full component set as the initial
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input set. In the experiment, a Gaussian Kernel with default parameter σ = 2 was
used. The kernel alignment values and the leave-one-out errors were calculated and
stored for each of the iterations of the algorithm. In Figure 4.2.1, we show 8 plots
(two for each of the four data sets) to illustrate the results of component selection
for each data set. The upper plot shows the kernel alignment value for each reduced
component set (labeled with the number of component left in the data set). The
lower plot shows the leave-one-out validation error vs. the number of components
left in the data set.
In Figure 4.2.1, we observe a general trend across all 4 data sets: When the
kernel alignment value decreases, the leave-one-out error increases. This provides
further evidence that Theorem 4.2.7 holds true for a practical data set.
4.2.6 Random Subspace Kernel Alignment Component Se-
lection (RSKACS)
For the Kernel Alignment Component Selection Algorithm, we began with the full
set of components, and then each component was individually eliminated from the
current subset. The major concerns about this algorithm are:
1. It is computationally intensive when the number of components is large.
2. The resulting component subset may represent a local maximum but not
necessarily a global maximum.
To address these points, we consider a randomized approach called Random
Subspace Kernel Alignment Component Selection (RSKACS) based on the random
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Figure 4.2.1: KACS Results for 4 different UCI data sets
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subspace method introduced by Ho [44, 64].
Suppose we have a large number of components. Instead of starting the KACS
algorithm with the full set of components, the RSKACS approach starts the algo-
rithm with a much smaller subset that is randomly selected from the full set. With
a smaller starting set, KACS will perform more efficiently. We randomly select t
different initial subsets. To ensure that we work with most of the components in
the dataset, we assume that t is reasonably large.
For each initial subset, denoted by Xsubi , where i = 1, .., t, we apply KACS on
Xsubi . The KACS algorithm will generate a reduced subset for each initial subset
until the stopping condition takes effect. The reduced subset containing the highest
kernel alignment value will be the final subset of the RSKACS. The final selection
criteria can be based on a combination of kernel alignment value, leave-one-out error
and the size of the selected subset. This can be further investigated by the user
of the RSKACS algorithm. Here, for simplicity, we only use the kernel alignment
value as our final selection criteria.
The following pseudo-code summarizes our algorithm:
1 Random Subspace Kernel Alignment Component Selection Algo-
rithm
2 Input: training set X, label set y, stopping condition sc, number of selections
t, size of initial subspace s.
3 for i = 1: t
4 Generate a random component subset Xsubi ⊂ X with size s.
CHAPTER 4. Component Selection 82
5 Apply the KACS Algorithm on Xsubi with the given y, and sc.




8 return Xsubi that give the maximum kernel alignment value;
4.3 Experimental Results - Experiment 1:
Binary Response QSAR Data
4.3.1 Data
In our QSAR study, three different data sets were used to test the performance
of the KACS algorithm. The three QSAR data sets are from Xue et al. [113]
The first data set contains the report of human intestinal absorption (HIA) of
chemical agents. HIA is an important indicator of drug absorption. In a total of
196 molecules, 131 molecules have been classified as absorbable and the remaining
65 are classified as non-absorbable. The second data set reports on P-glycoprotein
(Pgp) substrates. There are 116 substrates and 86 non-substrates of Pgp in the
data set. The third data set reports on compounds that induce torsades depointes
(TdP). TdP is an uncommon adverse drug reaction responsible for the withdrawal
of some marketed drugs. In a total of 361 molecules, 85 of them are classified as
TdP positive and the remaining 276 are classified as TdP negative.
The descriptors used in this experiments were selected by Xue et al. [113]. They
use 159 descriptors that contain simple molecular properties, molecular connectiv-
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ity and shape, 3D geometrical properties, electro-topological state and quantum
chemical properties.
4.3.2 Implementation Details
To compare our proposed KACS and RSKACS with the SVMRCE, we used MAT-
LAB and SVMlight [48] to implement the KACS and the Gaussian version of
SVMRCE.
4.3.3 Results and Discussion
For the three data sets, Xue et al. [113] used 5 fold cross-validation to compare
the prediction accuracy of SVMRCE classification with a SVM that did not use
any component selection method. The data was randomly divided into five subsets
for the purpose of cross-validation. To provide a fair comparison, we used leave-
one-out cross-validation to ensure that all component selection algorithms were
trained and tested using the same data. The parameter σ = 2 was also fixed for
all component selection algorithms. For each of the iterations of the algorithm,
only one component was removed. For each of the data sets, component values
were normalized. Leave-one-out errors were calculated at each iteration step for
the purpose of comparison. For the RSKACS, we set t = 500 and s = j + 1, where
j is the current number of iteration in our experiments.
Figure 4.3.2 summarizes the results of the KACS Algorithm on the HIA data
set. We observe that when the kernel alignment value decreases, the leave-one-out
error increases. The maximum kernel alignment value is 0.2041 with 85 components
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left and the leave-one-out error at the corresponding kernel alignment value is at a
minimum which is 0.1633.
Figure 4.3.2: The results of the KACS Algorithm on the HIA data set
Figure 4.3.3 compares the leave-one out error generated by the KACS algorithm,
RSKACS algorithm and the SVMRCE algorithm on the HIA data set. It can be
seen that a lower leave-one-out error is achieved by our KACS algorithm for all
the iterations, indicating that the algorithm performs significantly better than the
SVMRCE algorithm on the HIA data set. The RSKACS algorithm also performs
very well for all the iterations.
Figure 4.3.4 summarizes the results of the KACS Algorithm on the Pgp data
set. The maximum kernel alignment value is 0.0638 with 55 components left. The
corresponding leave-one-out error is at a minimum which is 0.2090.
Figure 4.3.5 compares the leave-one-out error generated by the KACS algorithm,
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Figure 4.3.3: The leave-one out error generated by the KACS, the RSKACS and
the SVMRCE algorithm on the HIA data set
Figure 4.3.4: The results of the KACS Algorithm on the Pgp data set
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the RSKACS algorithm and the SVMRCE algorithm on the Pgp data set. It can
be seen that in the first 50 iterations, both algorithms perform almost the same by
selecting roughly the same set of components for elimination. However, after 50
iterations, the KACS algorithm performs significantly better than the SVMRCE
algorithm in the Pgp data set by finding a better set of components. Due to the
random effect on the RSKACS algorithm, the leave-one-out error generated by the
RSKACS algorithm fluctuated from 0.21 to 0.33 across all iterations.
Figure 4.3.5: The leave-one out error generated by the KACS, the RSKACS and
the SVMRCE algorithm on the Pgp data set
Figure 4.3.6 summarizes the results of the KACS Algorithm on the TdP data
set. We observed that when the kernel alignment value decreases, the leave-one-out
error typically increases. The maximum kernel alignment value is 0.3090 with 40
components left and the leave-one-out error at the corresponding kernel alignment
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value is at a minimum which is 0.1662.
Figure 4.3.6: The results of the KACS Algorithm on the TdP data set
Figure 4.3.7 compares the leave-one out error generated by the KACS algorithm,
the RSKACS algorithm and the SVMRCE algorithm on the Tdp data set. It can
be seen that by using our KACS algorithm and RSKACS algorithm, we obtained
a lower leave-one-out error for most of the iterations after the first 15 iterations,
indicating that our KACS algorithm and RSKACS algorithm perform significantly
better than the SVMRCE algorithm on the TdP data set.
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Figure 4.3.7: The leave-one out error generated by the KACS, the RSKACS and
the SVMRCE algorithm on the TdP data set
4.4 Experimental Results - Experiment 2:
Continuous Response QSAR Data
4.4.1 Data Set
In this QSAR study, four different data sets were used to test the ability of the
KACS to select important components. All these data sets contain continuous
response QSAR inhibitor data.
The four QSAR data sets were selected from Sutherland et al. [96]. The first
data set contains 114 angiotensin converting enzyme (ACE) inhibitors collected by
Depriest and colleagues [20] with pIC50 values ranging from 2.1 to 9.9. The second
data set contains 322 cyclooxygenase-2 (COX2) inhibitors collected by Seibert and
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colleagues [46] and subsequently utilized in a QSAR study by Chavatte et al. [12]
with inhibitors having pIC50 values ranging from 5.5 to 8.9. The third data set
contains 397 dihydrofolate reductase inhibitors (DHFR) collected by Queener and
colleagues [9] and set up as data sets by Sutherland and Weaver [97] with inhibitors
having pIC50 values for rat liver enzyme ranging from 3.3 to 9.8. The final data set
were prepared by Klebe and his colleagues [60] including 88 thrombin inhibitors
(THR) with pKi values ranging from 4.4 to 8.5.
In all our experiments the data were separated into the same training and testing
sets used in Sutherland et al. [96]. Leave-one-out cross validation was used to
obtain the parameters for the model.
4.4.2 Results and Discussion
The descriptor used in this experiment is our VSMMD descriptor. As reported
in an earlier chapter, our modeling mechanisms have produced very effective al-
gorithms to predict drug-binding affinities. For regression analysis, we made use
of a linear ε-insensitive Support Vector Regression (SVR) algorithm as mentioned
in the previous chapter. In our experiments, ε was set to 0.1, fragment type ID
of the VSMMD was set to 1 and the Gaussian kernel was used for the SVR. Two
parameters, σ and C, had to be evaluated through cross-validation. For all four
data sets, we choose the best σ and C by cross-validation using only the training
set.
The Kernel Alignment Component selection algorithm was run on the full com-
ponent set using a Gaussian Kernel with the selected σ. For regression, we modified
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the Kideal by centering the response as:
Kideal = y
∗y∗T where y∗ = y − ȳ.
In this equation, ȳ represents the mean evaluated over the training set of target
values. For the reduced model generated by the KACS algorithm, we performed
leave-one-out cross validation on the training set only, to obtain the optimal values
for the two parameters C and σ.
For the RSKACS, we set t = 500 and s = 1
2
m, where m is the total number of
components in our experiments. For the reduced model generated by the RSKACS
algorithm, we performed leave-one-out cross validation on the training set only, to
obtain the optimal values for the two parameters C and σ.
The prediction accuracy was assessed using the designated test sets and residual
r2 statistics [42] were obtained. A residual r2 value close to one indicates a good
prediction.
The residuals r2 as well as the cross-validation residual q2, for all the four data
sets are given in Table 4.4.2.
Full Model (m=147) KAFS Reduced Model RSKAFS Reduced Model
r2 q2 Std(q2) r2 q2 Std(q2) m r2 q2 Std(q2) m
ACE 0.45 0.63 0.087 0.5 0.68 0.041 52 0.47 0.63 0.055 78
COX2 0.35 0.37 0.134 0.42 0.41 0.093 133 0.42 0.35 0.169 98
DHFR 0.53 0.57 0.068 0.56 0.58 0.097 129 0.57 0.61 0.081 65
THR 0.16 0.2 0.201 0.24 0.23 0.134 24 0.17 0.21 0.146 115
Table 4.4.2: r2 statistics using SVR on the testing set
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From Table 4.4.2, the residual r2 statistics based on the KACS and RSKACS
methods increased across all four data sets.
In these two experiments, we have demonstrated that both the KACS algorithm
and RSKACS are capable of automatic selection of important components in both
binary QSAR data and real value QSAR data. The reductions of some overlapping
and redundant molecular components in a descriptor enhance the performance of
kernel based machine learning algorithms.
4.5 Conclusion
While the use of component selection techniques has appeared several times in
research studies dealing with quantitative structure-activity relationships, we have
further developed a new filter based component selection algorithm that is suitable
for kernel based prediction algorithms. Our contributions include:
1. We have utilized a kernel alignment value as a relevance measure that is
independent of the performance of the classifier.
2. We have developed a filter based kernel alignment component selection algo-
rithm.
3. We have shown theoretically and empirically that our algorithm kept the
component subset that maximimized the kernel alignment value, which can
produce a lower generalization error bound in an SVM classifier.
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Empirical results show that our algorithm works well for finding the most important
components in different QSAR data sets. The prediction accuracies are substan-
tially increased and compare favorably with those from the earlier studies.
Chapter 5
Multiple Binding Modes
The ligand may show evidence of multiple binding modes within the same binding
site. The same ligand can bind in distinct orientations or conformations in the
binding site. The information of binding affinities for each mode are usually com-
bined and packed as a whole in the training set. To disentangle this information is
a challenge and thus complicates the machine learning strategy.
In this chapter, we extend the VSMMD to the prediction of multiple binding
modes through the use of a standard k-means algorithm in the feature space.
5.1 Introduction
Most of the QSAR studies mentioned earlier rely on an assumption stated as follows:
“similar analogs bind to the same binding site in a similar binding mode.” [54, 55]
Usually, multiple binding modes of a binding site are completely ignored or treated
as outliers in the modeling process. However, it is well known that reliable predic-
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tion of correct binding modes of active compounds identified from high-throughput
or virtual screening will facilitate the drug discovery process and provide results
that are more accurate.
In this chapter, we describe the use of our reported novel descriptors, the vector
space model molecular descriptor (VSMMD), based on a vector space model that is
suitable for kernel studies in QSAR modeling, together with a kernel feature space
algorithm to identify the binding modes in kernel feature space. Two different data
sets:
1. Anilinopyrazoles as CDK2 inhibitors;
2. 6,9-diarylpurin-8-ones as inhibitors in the ATP binding site of p38 MAP ki-
nase;
were chosen for the experiment. The inhibitors in both data sets can adopt mul-
tiple binding modes depending on the substituents. Previous studies [85, 41] have
shown that it was difficult for docking programs to identify the alternative binding
mode. Our experiments provide convincing empirical evidence that our VSMMD
can provide sufficient information to identify different binding modes of a molecule
with high accuracy.
5.2 The kernel k-means algorithm
In order to visualize the different binding modes, we applied the k-means algorithm
to cluster image points in the RKHS. Clustering is one of the most important and
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widely used methods of unsupervised learning. The algorithm has the ability to
partition data into dissimilar groups of similar items.
Suppose we are working with n molecules (d1, · · ·dn), and we wish to find an
assignment of each point to one of a finite number g of classes. In other words, we
seek a map:
f : (d1, d2, · · · dn)→ (1, 2, · · · , g). (5.2.1)
This cluster mapping function f should be chosen to optimize:
f = arg min




where φ maps into inner product space feature space FS using:
k(di, dj) = 〈φ(di), φ(dj)〉 . (5.2.3)
According to Shawe-Taylor and Cristianini [89], the solution of the clustering opti-
mization function equation (5.2.2) can be found in the form:
f(di) = arg min
16z6g
‖φ(di)− Cz‖ (5.2.4)
where Cz is the centroid of the points assigned to cluster z. A detailed proof can
be found in [89]. We can also derive the generalization form of equation (5.2.4) as:
f(.) = arg min
16z6g
‖φ(.)− Cz‖ (5.2.5)
The k-means algorithm keeps a set of cluster centroids C1, C2, · · · , Cg that are
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By adapting both f as well as the centers, the algorithm will converge to a solution
in which Cz is the center of mass of points assigned to cluster z and will satisfy the
criterion of equation (5.2.4).
The algorithm alternates between updating f to adjust the assignment of points
to clusters and updating the Cz giving the positions of the centers in a two stage
iterative procedure. The first stage simply assigns points to the cluster whose
cluster center is closest. The second stage repositions the center of each cluster to
be the center of mass of the points assigned to that cluster. Note that each stage
can only decrease the value of expression (5.2.6) [89]. Since the number of possible
clusters is finite, it follows that after a finite number of iterations the algorithm will
converge to a stable clustering assignment.
Shawe-Taylor and Cristianini [89] provide a dual form solution to this problem.







1 if di is in cluster z;
0 otherwise.
(5.2.7)
Note that each row of A contains exactly one 1, while the column sums give
the number of points assigned to the different clusters. Using A, we can compute
the coordinates of the centroids Cz using FAD, where F is the m × n matrix of
training molecules as in (3.3.2), and D is a diagonal g × g matrix with diagonal
entries equal to the inverse of the column sums of A. Now we can compute the
distance between a new point φ(d) and the centroid by:
‖φ(d)− Cz‖2 = ‖φ(d)‖2 − 2 〈φ(d), Cz〉+ ‖Cz‖2
= k(d, d)− 2(kTAD)z + (DATFTFAD)zz
(5.2.8)
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where k is the vector of inner products between φ(d) and the training samples.
Hence, the cluster to which φ(d) should be assigned is given by:
arg min
16z6g






where K is the kernel matrix of the training set. This provides the rule for classi-
fying new data. The update rule consists in reassigning the entries in the matrix
A according to the same rule in order to redefine the cluster.
5.3 Experimental Results
5.3.1 Data
Two different data sets were used to test the ability of the VSMMD to identify
multiple binding modes. The first data set contains 63 CDK2 inhibitors, anilinopy-
razole, collected by Sato et al. [85]. The compounds are divided into two groups
(Type A and Type B) based on the substituents at the 5-position of the pyrazole
ring (See Figure 5.3.1). Sato et al. [85] found two different binding modes (See
Figure 5.3.2) from two representative compounds, one from each group, among the
65 compounds in their studies. The type-A representative compound is in binding
mode 1, and the type B representative compound is in binding mode 2.
The second data set contains ten p38 MAP Kinase Inhibitors prepared by Hauser
et al. [41]. Two different binding modes have been reported (See Figure 5.3.3). The
free energy of binding (FEB) is reported for the two different binding modes in Table
5.3.1.
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Figure 5.3.1: Type A and Type B compound of anilinopyrazole, a CDK2 in-
hibitor [85]
Figure 5.3.2: Two different binding modes reported of anilinopyrazole, a CDK2
inhibitor [85]
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Figure 5.3.3: Two different binding modes reported for p38Map inhibitor [41]
Molecule ID IC50(µM) Best FEB FEB
binding of binding of binding
mode mode 1 mode 2
21 0.9 1/2 -8.7 -8.7
22 7.8 1 -9.4 -9.2
23 2.7 1 -8.8 -8.7
24 17.5 1/2 -8.2 -8.2
25 18.1 1 -9.4 -8
26 0.5 2 -8.7 -8.8
27 1.6 2 -8.7 -8.9
28 5.2 2 -8.8 -9.2
29 7.8 1 -8.5 -6.9
30 100 2 -9.2 -9.4
Table 5.3.1: Free Energy of Binding (FEB) of ten p38 MAP Kinase Inhibitors
reported by Hauser et al. [41]
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5.3.2 Implementation Details
For the kernel k-means algorithm, we used MATLAB to perform the clustering
experiments.
5.3.3 Test Results
To test our descriptor’s ability to facilitate the prediction of multiple binding modes,
we generated the VSMMD kernels of different lengths using equation (3.3.3), and
then we used the data fusion equation (3.4.5) to average the kernels to form a
final kernel matrix K. Finally, we applied the kernel k-means algorithm to the final
kernel matrix K.
Since the optimization of k-means algorithm is not convex, there is the possi-
bility that the algorithm will converge to a local minima. In order to reduce the
effect of local minima, the reported results are based on 100 runs of the k-means
algorithm. Since we believed that there are two binding modes associated with
each data set, for our experiment, we used k = 2. The result of the k-means al-
gorithm will classify the molecules into either one of the two clusters, each cluster
representing a binding mode. Table 5.3.2 summarizes the clustering result for the
anilinopyrazole data set. Table 5.3.3 summarizes the clustering result for the p38
MAP Kinase Inhibitors data set.
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Compound IC50 Best Clustering Compound IC50 Best Clustering
binding binding binding binding
mode mode mode mode
1 5.2 1 1 33 7.63 1 1
2 5.2 1 1 34 7.76 1 2
3 5.23 1 1 35 7.9 1 2
4 5.32 1 1 36 7.97 1 1
5 5.36 1 1 37 7.97 1 1
6 5.36 1 1 38 8 1 2
7 5.51 1 1 39 8.04 1 1
8 5.53 1 2 40 8.11 1 1
9 5.56 1 2 41 8.76 1 1
10 5.57 1 1 42 9.48 1 1
11 5.65 1 2 43 5.35 2 2
12 5.65 1 2 44 5.36 2 2
13 5.67 1 2 45 5.38 2 2
14 5.69 1 1 46 5.42 2 2
15 5.73 1 1 47 5.51 2 2
16 5.81 1 1 48 5.54 2 2
17 5.81 1 1 49 5.62 2 2
18 5.89 1 2 50 5.67 2 2
19 5.95 1 2 51 5.68 2 2
20 6.03 1 1 52 5.86 2 2
21 6.04 1 1 53 5.86 2 2
22 6.06 1 2 54 5.89 2 2
23 6.22 1 2 55 5.94 2 2
24 6.22 1 1 56 5.98 2 2
25 6.31 1 1 57 6.04 2 2
26 6.39 1 2 58 6.26 2 2
27 6.45 1 2 59 6.28 2 2
28 6.49 1 2 60 6.49 2 2
29 6.78 1 1 61 6.76 2 2
30 6.9 1 1 62 6.76 2 1
31 7.21 1 1 63 6.79 2 2
32 7.61 1 1
Table 5.3.2: k-means clustering result for anilinopyrazole data based on 100 runs.
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Molecule IC50 Best binding mode Clustering binding mode
21 0.9 1/2 1
22 7.8 1 2
23 2.7 1 1
24 17.5 1/2 1
25 18.1 1 2
26 0.5 2 2
27 1.6 2 2
28 5.2 2 2
29 7.8 1 1
30 100 2 2
Table 5.3.3: k-means clustering result for p38 MAP Kinase Inhibitors data based
on 100 runs.
5.3.4 Discussion
For the anilinopyrazole data set, Sato et al. [85] identified two representative com-
pounds in their experiments: compound 33 and compound 47. According to their
crystal structure experiments [101], compound 33 has binding mode 1 while com-
pound 47 has binding mode 2. Sato et al. [85] also performed docking simulations
using various docking programs, including FlexX [81, 7, 61], GOLD [49, 50, 51] and
LigandFit [105]. When type-A compounds were docked, docking programs could
find the correct binding mode. However, no docking programs found the alternative
binding mode of type-B compounds without a template constraint1. For example,
1A template is the desired position of another ligand in the receptor. It provides an example
for the docking program to perform constrained docking.
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in order to reproduce binding mode 2 using the docking program GOLD, the pro-
gram required a template constraint, based on the crystal structure of compound
47, to get a successful docking simulation.
As shown in Table 5.3.2, our feature space clustering experiments, based only on
ligand information, predict that compound 33 has binding mode 1 and compound
47 has binding mode 2. More significantly, most of the type-B compounds have
binding mode 2 as suggested by our result. As mentioned by Sato et al. [85]: “...
the binding mode of type-B compounds was more complicated than what we could
expect from the experimental evidences.” In terms of statistics, for binding mode
1, we have an accuracy value of 68.52%; for binding mode 2, we have an accuracy
value of 94.14%; and so the weighted average accuracy is 74.60%. With our high
accuracy in predicting binding mode 2, one can apply our methodology first before
performing a docking simulation to determine whether a template constraint is
necessary.
For the p38 MAP Kinase Inhibitors, Hauseret et al. [41] produced a series of
6,9-diarylpurin-8-ones as inhibitors in the ATP binding site of p38 MAP kinase.
According to their crystal structure experiments, some compounds belong to bind-
ing mode 1 while others belong to binding mode 2. The binding mode of inhibitors
in the ATP binding site of p38 MAP kinase is determined by both hydrogen bonds
and a lipophilic interaction. To determine which binding mode a compound belongs
to, a balance of both types of interaction should be made. Hauseret et al. [41] also
performed a docking simulation using various docking programs, including FlexX
and Autodock. According to Hauser et al. [41] , Autodock performs well in the
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case of p38 MAP kinase giving similar docking results for the structurally similar
inhibitors of the purin-8-one series. In contrast, the docking program FlexX does
not predict a consistent binding mode.
As shown in Table 5.3.3, our clustering experiment correctly identified all com-
pounds (Compounds 26, 27, 28, and 30) that belong to binding mode 2. In terms
of statistics, for binding mode 1, we have the accuracy value of 66.7%; for binding
mode 2, we have the accuracy value of 100%; the weighted average accuracy is 80%.
It should be noted that clustering applied directly to the input space data did not
successfully predict any alternate binding modes.
5.4 Conclusion
In conjunction with a kernel based clustering algorithm, we extended the VSMMD
to the prediction of multiple binding modes, a challenging area of research that
has been previously studied by means of time consuming docking simulations. The
results reported in this chapter provided strong empirical evidence that our strategy
has enough resolving power to distinguish multiple binding modes through the use
of a kernel k-means algorithm. This has various applications. For example, using
our techniques as a pre-processing step prior to a docking exercise would help to
designate the template that could be used to hunt for an alternative binding mode.
Chapter 6
Inverse QSAR
A common assumption in supervised learning is that the components of the descrip-
tors from the training and testing data are independently and identically (i.i.d.)
drawn from same probability distribution. However, this assumption is difficult to
guarantee, especially in traditional ligand-based drug design. In traditional ligand-
based drug design, we can define various data sets: training data set, validation
data set, testing data set and application data set. The first two data sets are
used to derive the predictor and the testing data set is used to get a measure of
success for the predictor. Note that in all these cases, we know the affinities of the
ligand and it is likely that the probability distribution constraint can be met. The
application data set is the set of ligands on which the predictor will be used in the
future to get a new drug candidate. For this set, we do not know the affinities and
it is difficult for one to guarantee the probability distribution constraint.
Let us consider a regression problem of learning f(X) from training data, where
X contains the descriptors of the data. We assume that Y = f (X) + ε ,
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where E(ε) = 0 and V ar (ε) = σ2ε . Suppose the application data descriptors
independently follow a probability distribution with density pa (X) and the training
data descriptors independently follow a probability distribution with density pt (X)























The first term is the bias and the second term is the variance. The situation where
the training and application distributions are different is referred to as the situation
under the covariate shift or the sample selection bias [95]. When pt (X) 6= pa (X) ,
two difficulties arises in a learning process:
• Prediction can be inaccurate if the region with high application data density
has low training data density.
• Cross-validation can be heavily biased, because the generalization error is
over-estimated in the high training data density region and it is under-estimated
in the high application data density region.
In traditional ligand-based drug design this is rarely, if ever, discussed. The
predictor is often applied to application molecules that have very little relationship
to the training data. In these cases, the predictor is optimistically treated as if it
actually incorporates an algorithm that has some firm and direct relationship to
the biological context of the problem.
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In this chapter, we try to sidestep such concerns. We develop a set of reverse
engineering strategies for QSAR modeling, based on our VSMMD, that actually
generate the structure of a new drug candidate. While the training set is still
used to generate a new image point in the feature space, the reverse engineering
strategies allow us to develop a new drug candidate that is independent of issues
related to probability distribution constraints placed on the descriptors in testing
or application set.
6.1 Introduction
In the previous chapters, we strive to establish the quantitative dependency between
the molecular properties of a ligand and its binding affinity or binding modes. In
contrast to this approach, the inverse-QSAR problem seeks to find a new molecular
descriptor from which one can recover the structure of a molecule that possesses
a desired activity or property. Surprisingly, there are very few papers providing
solutions to this problem [22]. It is a difficult problem because the molecular de-
scriptors involved with the inverse-QSAR algorithm must adequately address the
forward QSAR problem for a given biological activity if the subsequent recovery
phase is to be meaningful. In addition, one should be able to construct a feasible
molecule from such a descriptor. The difficulty of recovering the molecule from its
descriptor is the major limitation of most inverse-QSAR methods.
Most of the proposed techniques are stochastic in nature (see papers such as
[90, 106, 62]). A limited number of deterministic approaches have been developed
including Kier and Hall’s [39, 38, 53] approach based on a count of paths, and a
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strategy based on signature descriptors (See Faulon et al. [14, 25, 23, 24]).
The key to an effective method lies in the use of a descriptor that facilitates the
reconstruction of the corresponding molecular structure. Ideally, such a descriptor
should be informative, have good correlative abilities in QSAR applications, and
most importantly, the construction of the descriptor should be computationally
efficient. A descriptor should also have a low degeneracy, that is, it should lead to
a limited number of solutions when a molecular recovery algorithm is applied.
Currently, kernel methods are popular tools in QSAR modeling and are used to
predict attributes such as activity towards a therapeutic target, ADMET properties
(absorption, distribution, metabolism, excretion, and toxic effects), and adverse
drug reactions. Various kernel methods based on different molecular representations
have been proposed for QSAR modeling [4]. They include the SMILES string
kernel [100], graph kernels [28, 72, 80] and a pharmacophore kernel [71]. However,
none of these kernel methods have been used for the inverse-QSAR problem.
In this chapter, we investigate the reversibility of our previously reported de-
scriptor, the vector space model molecular descriptor (VSMMD). VSMMD is based
on a vector space model that is suitable for kernel studies in QSAR modeling. Our
approach to the inverse-QSAR problem consists of first deriving a new image point
in the kernel feature space and then finding the corresponding pre-image descriptor
in the input space. Then, we use a recovery algorithm to generate a chemical struc-
ture template suitable for high throughput screening. In section 6.2, we provide a
detailed description of our inverse-QSAR approach using our VSMMD approach.
In section 6.3, we present the experimental results of our descriptors in the vector
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space setting.
6.2 VSMMD Inverse-QSAR Approach
Our inverse-QSAR approach can be described in five steps. The first two steps are
to perform a QSAR analysis. In the first step, we generate a VSMMD for each
compound in the training set. A component selection algorithm is then used to
select the most important components of the initial VSMMD. Once these compo-
nent positions are determined for the descriptor vector, these components are used
across all initial descriptors of the training set to get the final descriptors. Then,
in the second step, we use a kernel function to map the VSMMD to a feature space
typically used for classification or regression analysis. The third step is to design
or to generate a new point in the kernel feature space using a kernel feature space
algorithm (e.g. the centroid of highly active compounds). In the fourth step, we
map this point from the feature space back to the input space using a pre-image
approximation algorithm. In the last step, the molecular structure template will
be built by our VSMMD molecule recovery algorithm. Figure 6.2.1 illustrates the
overall processing.
6.2.1 Vector Space Model Molecular Descriptor (VSMMD)
The first two steps for the inverse-QSAR approach are to perform forward QSAR
analysis. In the first step, we generate a VSMMD for each compound in the training
set as described in section 3.2. Next, the KACS algorithm described in section 4.2.
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Figure 6.2.1: Overall concept for the VSMMD inverse-QSAR approach.
is used to select the most important components of the initial VSMMD. Once these
component positions are determined for the descriptor vector, these components
are used across all initial descriptors of the training set to get the final descriptors.
Then, in the second step, we use a kernel function to map the VSMMD to the
feature space for classification or regression analysis as described in section 3.3.
6.2.2 Designing descriptor image point in feature space
Suppose we have a set of n molecular descriptors S, designated as S = {d1, d2, · · · , dn}
where each di is in the input space X. Let us assume we are using a Gaussian vector
space kernel as defined in (3.5.6). Under this kernel, any point di ∈ X, is implicitly
mapped to an image φ(di) in the feature space FS. With this kernel mapping, we
can define the set φ(S) = {φ(d1), φ(d2), · · · , φ(dn)} ∈ FS .
In this sub-section, we will evaluate various properties of the data set φ(S). We
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provide a set of elementary algorithms to do various calculations such as distance
between two descriptor image points in the feature space.
The feature space centroid derived from highly active compounds








A special case of the norm is the length of the line joining two images φ(d1)and
φ(d2), which can be computed using:
‖φ(di)− φ(dj)‖2 = 〈φ(di)− φ(dj), φ(di)− φ(dj)〉
= 〈φ(di), φ(di)〉 − 2 〈φ(di), φ(dj)〉+ 〈φ(dj), φ(dj)〉
= k(di, di)− 2k(di, dj) + k(dj, dj).
(6.2.3)
The norm described by (6.2.3) represents the distance between two descriptor
image points in the feature space. We define the centroid φs of the molecule data








The norm of the centroid can be calculated using only the evaluations of the kernel
on the inputs:
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Note that the result is the average of the entries in the kernel matrix. The inner


























Using equation (6.2.3), we can calculate the distance between φ(d) and the centroid
φs in the feature space by:
‖φ(d)− φs‖2 = ‖φ(d)‖2 − 2 〈φ(d), φs〉+ ‖φs‖2
















Recall that the kernel-based learning algorithms work by embedding the data
into the feature space, and searching for a linear relationship within this feature
space. With this linear relationship, it makes sense to derive a new descriptor image
point using the centroid point of the highly active compound’s image points which
will share the general properties of all highly active compounds. If the centroid
point can be mapped from the feature space back to the input space, we can obtain
the descriptor of a new candidate molecule. Figure 6.2.2 illustrates this idea. It
should be stressed that when a nonlinear kernel (such as the Gaussian kernel) is
used, then a point in the feature space bears a nonlinear relationship to the point
in the input space. The centroid in the feature space would rarely, if ever, map
back to the centroid in the input space. We have chosen to use the centroid in
the feature space because there is more assurance of generating a new point in the
feature space that in some sense represents a point of reasonable interpolation in
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this high dimensional space. Picking an arbitrary point in the feature space runs a
higher risk of extrapolation which may be difficult to avoid especially when a small
training set is spread over the higher dimensional feature space in some rarefied
manner.
Figure 6.2.2: Deriving a new image in kernel feature space.
The inverse in the input space is called the pre-image. We will discuss pertinent
details in the pre-image subsection.
There are several studies that use a feature space centroid to generate new
data. Kwok and his colleagues used a feature space centroid to generate a new
data point for hand-written digit recognition [63] and speech processing [74, 73]. In
both applications, the pre-image has been shown to be robust and meaningful. In
the next subsection we describe another strategy for the derivation of a new feature
space point.
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Minimum Enclosing and Maximum Excluding Hypersphere
In the last subsection, we derived a new descriptor image point using the centroid of
feature space images derived from the highly active compounds. In this subsection,
we use the highly active compounds to derive two hyperspheres with the same
center. The center of the hyperspheres is then mapped back from the feature space
to the input space to generate the descriptor of a new candidate molecule.
Suppose we can identify a subset G ⊆ S where G contains the descriptors of
molecules in the chemical space with the highest activity. We let |G| represent the
number of descriptors in G. In an ideal situation, the feature space images of G
will be spherically separable from all the other descriptor images mapped over from
S. With this assumption, we can derive two hyperspheres, sharing the same center
a, such that the images of all descriptors derived from highly active molecules are
enclosed by the inner hypersphere H1 and all the remaining images are excluded
by the outer hypersphere H2. Let r1 be the radius of the inner hypersphere and let
r2 be the radius of the outer hypersphere. Consequently, we have:
‖a− φ (di)‖2 6 r21 for di ∈ G,
‖a− φ (di)‖2 > r22 for di /∈ G.
(6.2.8)
Figure 6.2.3 illustrates this idea.
Following the development of Liu and Zheng’s minimum enclosing and maxi-
mum excluding machine (MEMEM) [68], we want the inner hypersphere H1 as
small as possible for a good description of the highly active class. In the meantime,
we want the outer hypersphere H2 as large as possible. In other words, we try
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Figure 6.2.3: Minimum enclosing and maximum excluding hypersphere in the fea-
ture space.
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to maximize the area between two hyperspheres H2 and H1. Note that the area
between two hyperspheres H2 and H1 is proportional to the quantity (r
2
2 − r21). Let
∆r2 = 1
2
(r22 − r21) and r2 = 12 (r21 + r22), we can formulate the objective function to
have r21 as small as possible and ∆r as large as possible by minimizing the quantity




Replacing the constant 1
3
by η, which controls the trade off between the importance









‖a− φ (di)‖2 6 r2 −∆r2 for di ∈ G, and
‖a− φ (di)‖2 > r2 + ∆r2 for di /∈ G.
(6.2.11)
Our analysis will require Lagrange multipliers αi and labels yi such that
yi = 1 for di ∈ G
yi = −1 for di /∈ G.
(6.2.12)



























αi = 1, and αi > 0 for i = 1 to n. (6.2.14)
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In practice, the data may not be separable in this fashion. By introducing slack












‖a− φ (di)‖2 6 r2 −∆r2 + ζi for di ∈ G,
‖a− φ (di)‖2 > r2 + ∆r2 − ζi for di /∈ G,
and ∆r2 > 0.
(6.2.16)
By using equation (6.2.15), we allow some negative samples inside the inner hyper-
sphere and some positive samples outside the outer hypersphere. The corresponding



























αi − β = 1, β > 0, and C > αi > 0 for i = 1 to n, (6.2.18)
where β is the Lagrange multiplier associated with the constraint ∆r2 > 0 , and C
is some constant to be determined with a validation data set.
The center a of the hyperspheres is then mapped back from the feature space
to the input space to generate the descriptor of a new candidate molecule.
6.2.3 The Pre-Image Problem
In Section 2.2.3, we illustrated how a point in the input space is mapped to the
feature space via the implicit function φ . In this section, we are interested in
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finding how a point in the feature space can be mapped back to the input space.
Formally, this is called the pre-image problem of reconstructing patterns from their
representation in feature space (see Fig. 6.2.4).
Figure 6.2.4: The pre-image Problem.
Let Ψ be a point in the Reproducing Kernel Hilbert Space (RKHS) FS. The
pre-image of Ψ ∈ FS is a point d∗ ∈ X (the original input space). Formally,
Ψ = φ(d∗). (6.2.19)
The problem of finding the pre-image d∗ is equivalent to the problem of finding the
inverse function of φ defined in equation (6.2.19):
d∗ = φ−1(Ψ). (6.2.20)
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However, the problem of finding φ−1(.) is a typical ill-posed problem. A problem
is said to be ill-posed if the solution is not unique, does not exist, or is not a
continuous function of the data [76].
One possible way to overcome this problem is to look for d̂∗ an approximation
of the pre-image such that φ(d̂∗) is as close as possible to Ψ. Formally, we search
for d̂∗ ∈ X, such that
d̂∗ = arg min
d∈X
‖φ(d)−Ψ‖2F . (6.2.21)
Typically, we will have Ψ defined as some linear combination of implicit mappings
from the input space. Consequently, expanding equation (6.2.21), we get:




















which can be rewritten as:

















Using equation (6.2.23), an inversion problem turns out to be an optimization
problem. There are several algorithms that attempt to solve this optimization
problem. Schölkopf et al. [86] proposed an iterative fixed point algorithm strategy.
Kwok and Tsang [63] proposed another method that exploits the correspondence
between distances in the input space and the feature space. Also, a standard
gradient optimization method can be used to find an approximation of the pre-image
[86]. Note that all these methods are only guaranteed to find a local optimum.
In this thesis, we are going to follow Kwok and Tsang [63] and use their approach
to approximate the pre-image. Their algorithm is based on the notion of distance
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constraints. They assume that there exists a simple relationship between distances
in the input space and distances in feature space. Figure 6.2.5 illustrates these
relationships.
Figure 6.2.5: Kwok and Tsang pre-image strategy.
Suppose we have derived the center a of the hyperspheres using equation (6.2.17).
It was shown that the center a of the hyperspheres is a linear combination of the





αiyiφ(di). Recall that η is defined in equation
(6.2.17). The norm of the center can be calculated using only the evaluations of



























For each training sample di, we can derive dist
F
a,i = ‖a− φ(di)‖2 representing the
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square of the distance between the training sample image di and the center a of the
hyperspheres:
distFa,i = ‖a− φ(di)‖2 = 〈a, a〉 − 2 〈a, φ(di)〉+ 〈φ(di), φ(di)〉



























Using the Gaussian kernel as specified in equation (3.5.6) and an observation made
by Kwok and Tsang [63], the corresponding input space distance dista,i between







To speed up the algorithm (as observed by Kwok and Tsang [63]), only the p closest
training sample images of a will be considered. From (6.2.25), we can identify the p
closest neighbours of a in the feature space. Using (6.2.26), we can convert these p
closest neighbour distances in the feature space to their corresponding input space
distances. Let b be the vector representing these input space distances with
b = [dista,1, dista,2, · · · , dista,p]T . (6.2.27)
Their corresponding descriptors in the input space are d1, d2, · · · , dp ∈ Rm, and the





di. Let D = [d1, d2, · · · , dp] be a m × p matrix. To








where I is a p × p identity matrix, and 1 is a p dimensional vector with each
component equal to 1.
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Assuming matrix D is of rank q, we obtain the singular value decomposition
(SVD) of AT as:
AT = USV T = UZ, (6.2.29)
where U = [u1, u2, · · · , uq] is a m× q matrix with orthonormal columns composed
of the ui’s, and Z = [z1, z2, · · · , zp] is a q × p matrix with the i-th column zi being
the projection of di on to uj’s such that the squared distance of di to the origin is
equal to ‖zi‖2. Let b0 =
[
‖z1‖2 , ‖z2‖2 , · · · , ‖zp‖2
]T
, the pre-image d̂∗ of the center
a can be obtained by:
d̂∗ = −1
2
US−1V T (b− b0) + d̄. (6.2.30)
6.2.4 The Need for a Nonlinear Kernel
The nonlinear implicit mapping provided by the kernel operation allows us to gen-
erate an inner product in the feature space by computing a kernel function that has
arguments taken from the input space. More significantly, when a nonlinear kernel
is used, linear operations in the feature space correspond to nonlinear operations
in the input space. This is important because the nonlinear mapping will involve
various cross products of components within a vector of the input space. As a
consequence, linear structures within the feature space correspond to nonlinear or
.warped. structures in the input space.
To illustrate this, we ran a small experiment with the COX2 training set (de-
scribed in the later section): As described earlier, the new feature space point a,
generated by extracting the center of the enclosing hypersphere, was mapped back
to the input space to get its pre-image d̂∗ . We then formed the set Sfe of points in
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the input space (taken from the training set) that produced the ten closest neigh-
bours of a under the kernel mapping. This set Sfe was compared with the set
Sin containing the 10 closest neighbours of d̂
∗ in the input space (these neighbours
derived using the Euclidean metric). Because of the warping effect, pre-images of
close neighbours in the feature space are not necessarily the closest neighbours of
the pre-image d̂∗ in the input space, in fact, the intersection of Sin and Sfe is only 3
descriptors. More significant: the average affinity of molecules in Sin is 8.03 while
the average affinity of molecules in Sfe is 8.73. This provides empirical evidence
that the nonlinear mapping provided by the kernel function helps us to select input
space descriptors that are more significant when considering their corresponding
affinities.
6.2.5 Recovering the molecule
In order to solve the recovery problem for chemical structures, we have to investigate
a way to derive a graph representing the 2D structure of a molecule that has d̂∗ as its
descriptor. There are several related studies that attempt to find such a graph, for
example, Bakir et al. [5] who worked with a stochastic search algorithm. However,
this recovery problem is not well studied from a computational viewpoint. Akutsu
and Fukagawa [2, 3] proposed a dynamic programming algorithm for inferring a
chemical structure from a descriptor. However, the algorithms are not practical for a
large data set. Previous studies focused on creating a real chemical structure, which
defined too many constraints on the problem due to the complexity of chemical
structure. In our study, we do not attempt to recover a real chemical structure;
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instead, we generate a chemical structure template with physiochemical properties
only. This simplifies the problem and makes it practical for real data sets.
6.2.6 Reversible VSMMD
For illustration and without loss of generality, we will assume that the atom count
associated with the VSMMD is two, and we further assume all the aromatic rings
are replaced by “super atoms” containing all the rings’ physicochemical properties.
Figure 6.2.6 illustrates a simplified VSMMD using the same example as in Figure
3.1.1.
From Figure 6.2.6, we observe that the VSMMD model contains only the physio-
chemical properties of the chemical structure. As a result, for the recovery problem,
we do not attempt to recover the entire chemical structure. Instead, we attempt
to generate a chemical structure template with physiochemical properties only. A
chemical structure template converted from the molecule shown in Figure 6.2.6 is
illustrated in Figure 6.2.7.
In the next subsection, we define the notion of a structure template and show
how it can be derived.
Forming the De Bruijn Graph
A De Bruijn graph is a graph whose nodes are labeled by strings over some alphabet
and whose edges indicate some relations between the strings in nodes. In this
subsection, we use the De Bruijn graph as a data structure to derive a chemical
structure template.
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Figure 6.2.6: Simplified VSMMD with an aromatic ring treated as a super atom.
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Figure 6.2.7: An example of a chemical structure template.
If we consider a molecule to be comprised of molecular fragments then it is clear
that there is a hierarchical organization of these fragments. A linear fragment with
an atom count of three can be seen as containing two smaller fragments each with
an atom count of two and of course the two fragments overlap in the central atom.
If we restrict a fragment to have an atom count of two, then it will contain two
elementary fragments, namely two atoms, each labeled with their atom types.
Informally: The purpose of a De Bruijn graph is to provide a data structure
that shows how small fragments combine to build larger fragments. Since we wish
to handle ring structures using the simplification of a “super atom”, we will abuse
these concepts slightly and consider the fragments under discussion to be fragments
within a template as describe in the previous section.
Suppose we are dealing with fragments that have an atom count designated as
fa. The De Bruijn graph D is constructed in the following way: We provide a
vertex for each fragment that has an atom count equal to fa − 1. In our simplified
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case, fa = 2 and each vertex will represent an atom labeled with a physicochemical
property. We then add a bi-directional edge from vertex a to vertex b if the frag-
ments associated with these vertices are within a larger fragment with atom count
equal to fa. Each edge is weighted with a value representing the number of times
that this larger type of fragment occurs in the template.
Although we have been referencing the template in describing the construction
of D, it should be clear that it is possible to accomplish the generation of D by
processing the descriptor that represents this template. Figure 6.2.8 illustrates the
De Bruijn graph D generated from the VSMMD shown in Figure 6.2.6 .
Figure 6.2.8: The De Bruijn graph D for VSMMD shown in Figure 6.2.6.
The De Bruijn graph can be expanded by replacing each edge carrying weight c
with c unweighted edges, each with the same direction as the original edge. Figure
6.2.9 illustrate this expansion. Let M be the resulting unweighted De Bruijn graph.
From the VSMMD, we know the exact number of vertices that should appear in
the chemical structure template. With this information, we can derive a chemical
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Figure 6.2.9: The expanded graph M .
structure template from the De Bruijn graph by finding an Euler circuit of M .
All possible Euler Circuits
An Euler circuit is a circuit on the graph such that each edge is traversed exactly
once. Each traversal of an edge corresponds to the consumption of one instance of
a component in the VSMMD. The problem of finding an Eulerian circuit of a graph
is well known and there exists a linear time algorithm for its derivation [111]. The
following is the pseudocode of the Euler circuit recursive algorithm.
1 EULER(q)
2 Path ← none
3 For each unmarked edge e leaving q do
4 Mark(e)
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5 Path ← EULER(oppositevertex(e)) || Path1
6 endfor
7 Return Path
Each Euler circuit will represent the extraction of a unique chemical structure
template from the De Bruijn Graph M . Figure 6.2.10 shows a subset of all the
Euler circuits that can be generated. The circuit labeled with a ‘*’ corresponds to
the chemical structure template illustrated in Figure 6.2.6. The total number of
possible Euler circuits for the chemical structure in Figure 6.2.5 is 2700.
Figure 6.2.10: Some possible Euler circuits.
In order to generate all possible chemical structures associated with the VS-
MMD, we have to find all Euler circuits. Different chemical structure templates
correspond to the different possible orderings when traversing outgoing edges of
each vertex. This produces a factorial explosion with respect to the number of
outgoing edges of each vertex. Thus, finding all Euler circuits is not feasible.
1|| represents concatenation
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To overcome this, we have developed an algorithm that generates Eulerian cir-
cuits by doing a guided walk of the graph. During the walk we choose an outgoing
edge in a probabilistic fashion. The choice is dependent on statistics that are gath-
ered from the descriptors in the training set. To accomplish this, we have built a
statistical model that is used to estimate the probability of an Euler circuit.
Let E denote a path of N edges, that is, E = e1, e2, · · · eN . Then, by the
probability chain rule, we can obtain:




P (ei|e1, · · · , ei−1) (6.2.31)
To estimate the conditional probabilities P (ei|e1, e2, · · · , ei−1), we need train-
ing data consisting of a large number of Euler circuits each corresponding to some
particular molecular template. One can obtain these conditional probability dis-
tributions from the training data by keeping statistics on the dependency between
the next edge to traverse and the history of the previously traversed edges. Seen
as probabilities of traversal, we of course use normalized values so that the proba-
bilities of all possible “next-edges” sum to 1.0.
To simplify the statistical model, independence assumptions are made so that
each edge depends only on the last t edges. Consequently, we have a Markov
model that provides an approximation of how the fragments, each labeled with
physicochemical properties, are connected within the template. More precisely, our
model predicts traversal of ei based on previously traversed edges ei−1, ei−2, · · · , ei−t.
Formally, this is described as:
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P (ei|ei−t, · · · , ei−1) (6.2.32)
If we could handle unlimited amounts of training data, the maximum likeihood
estimate of P (ei|ei−t, · · · , ei−1) would be:
P (ei|ei−t, · · · , ei−1) =
c(ei−t, ei−t+1, · · · , ei−1, ei)
c(ei−t, ei−t+1, · · · , ei−1)
(6.2.33)
where c(ei−t, · · · , ei−1, ei) is the number of times the edge sequence ei−t, · · · , ei−1, ei
is seen in the training data.
As an example, consider Figure 6.2.11 with t = 1. In order to determine the
edge to be traversed next when at the node labeled “R”, we consult the associated
probabilities: P (R-O | A-R) and P (R-A | A-R). We traverse the edge with the
largest probability first.
Figure 6.2.11: An example in edges traversal.
A threshold h can also be used as a cutoff to limit the number of edges that
the algorithm should examine in an effort to sidestep the factorial explosion that
can occur without this limitation. With this understanding, we can compute the
overall probability of each Euler circuit using equation (6.2.32).
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With t = 1 and h = 2, a total of 102 Euler circuits are generated. The six Euler
circuits with highest probability are shown in Figure 6.2.12. They corresponded to
two unique chemical templates. Templates 1 and 3 are the exact templates derived
from the chemical structure shown in Figure 6.2.6.
Figure 6.2.12: Six highest probability Euler Circuits for VSMMD shown in Fig.
6.2.4 and the corresponding chemical structure templates.
There are several related research papers that attempt to retrieve the order
of elements that are part of a larger structure using Eulerian circuits. Cortes et
al. [15] retrieve the order of words in documents using an Eulerian circuit approach.
Pevzner et al. [79] assembly DNA fragments using an Eulerian circuit.
As mentioned in [63], in general, there was no exact pre-image in the input
space; The pre-image returned by the algorithm was an approximation and so it
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was compromised by approximation errors. Because of these approximation errors,
the following problems may exist:
• The pre-image vector may consist of non-integer components.
• The pre-image vector may not form a fully connected De Bruijn Graph.
Our solution to overcome the first problem is to round the components to obtain
integer counts. To deal with the case where the graph is not connected, the all-
possible Euler circuits algorithm is called at each vertex whose outgoing edges are
not all marked. The resulting path is the concatenation of the paths returned by
different calls to the all-possible Euler algorithm. More precisely, a bidirectional
edge with the largest conditional probability based on previously traversed edges
in the path, (using the same Markov model that we set up in the previous section),
is added to connect two Euler paths together.
Consider the pre-image example given in Figure 6.2.13 (a), the corresponding
expanded De Bruijn Graph is given in Figure 6.2.13 (b). The all-possible Euler
algorithm is called at each vertex whose outgoing edges are not all marked. The
highest probability Euler circuits for the disjoint De Bruijn Graph are given in
Figure 6.2.13 (c). To determine the concatenation location of the two Euler circuits,
our algorithm considers all the possible connections between the two disjoint parts
of the graph. All the possible connections are illustrated in Figure 6.2.13 (d).
These possible connections are evaluated using the same Markov model that we set
up before to calculate the Euler circuits. Among all the possible connections, the
P (R-O|R-R) value gives the highest probability. Thus a bi-directional edge between
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node ‘R’ and node ‘O’, is added to connect the two disjointed parts together. The
final De Bruijn Graph, the concatenated Euler circuit and the corresponding graph
template are shown in Figure 6.2.13 (e).
6.3 Experimental Results
6.3.1 Data
In our previous work [11], eight different data sets were used to test the ability
of the VSMMD to predict biological activities. All these data sets contain real
valued QSAR inhibitor data. The eight QSAR data sets are from Sutherland et
al. [96]. For illustrative purposes, we chose one data set from these eight data
sets to demonstrate the effectiveness of the recovery algorithm when applied to our
VSMMD.
The data set we chose contains 322 cyclooxygenase-2 (COX2) inhibitors col-
lected by Seibert and colleagues [46] and subsequently utilized in a QSAR study
by Chavatte et al. [12] with each inhibitor having pIC50 values ranging from 5.5
to 8.9. We chose this data set because training samples in the COX2 data set were
presented using diagrams of molecular structures. This allowed us to compare our
generated chemical structure templates with the given molecules in the data set.
The same inverse-QSAR procedure was applied to the remaining seven data sets,
the closest matching molecule in the test set for the generated chemical template
was shown in the last section.
In our experiments, the data were separated into the same training and testing
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Figure 6.2.13: A case where the pre-image vector did not form a fully connected
De Bruijn Graph.
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sets as specified by Sutherland et al. [96].
6.3.2 Implementation details
For the pre-image algorithm and the feature space algorithm, we used MATLAB
to perform the required calculations. For the recovery phase, we implemented the
Probabilistic Euler Paths algorithm in Java.
6.3.3 Verification of the Inverse Mapping - Test Result
To verify our proposed inverse approach, we picked one molecule in the COX2
training set randomly as shown in Figure 6.3.14(a). We then generated the VSMMD
for each of the compounds in the training set. The corresponding VSMMD for the
chosen molecule is shown in Figure 6.3.14(b). Next, we implicitly mapped this
VSMMD to the kernel feature space using a Gaussian kernel function as stated in
equation (3.5.6). Instead of generating a new point in the feature space, we used
the pre-image approximation algorithm to compute the pre-image of this feature
space point. The corresponding pre-image is shown in Figure 6.3.14(c). Finally, we
applied our VSMMD recovery algorithm to obtain a chemical template. With t =
1 and h = 3, we generated the Euler circuit with the highest probability and the
corresponding chemical structure templates are shown in Figure 6.3.14(d). From
this result, we observed that our approach is able to generate a chemical template
corresponding to the original chosen molecule.
CHAPTER 6. Inverse QSAR 137
Figure 6.3.14: Verification test result.
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6.3.4 Inverse-QSAR Test Results
Recall that our inverse-QSAR approach contains five steps. The first two steps
are to perform QSAR analysis. In the first step, we generated the VSMMD for the
compounds in the training set. The KACS algorithm is then used to select the most
important components of the initial VSMMD. Once these component positions are
determined for the descriptor vector, these components are used across all initial
descriptors of the training set to get the final descriptors. Then, in the second step,
we implicitly mapped the VSMMD to the kernel feature space using an appropriate
kernel function for classification or regression analysis. The results of the forward
QSAR can be found in our previous chapter.
The third step was to design or to generate a new point in the kernel feature
space using a kernel feature space algorithm. To demonstrate our approach, we
formed a new point in the feature space by using the ten highest active compounds
in the training set. The center of the minimum enclosing and maximum excluding
hypersphere was obtained. Figure 6.3.15 shows these ten compounds.
In the fourth step, we mapped the feature space point back into the input space
using the pre-image approximation algorithm. In this case, we used the Kwok and
Tsang algorithm [63] described in Section 6.2.4 to map the center of the minimum
enclosing and maximum excluding hypersphere back into the input space. Figure
6.3.16 illustrates the derived VSMMD.
The last step concerned building the molecular structure template using our
VSMMD recovery algorithm described in Section 6.2.5. Since the center of the
minimum enclosing and maximum excluding hypersphere was derived from the ten
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Figure 6.3.15: Ten highest active compounds in the COX-2 training set.
Figure 6.3.16: The pre-image VSMMD of the center of the minimum enclosing and
maximum excluding hyperspheres.
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highest active compounds in the training set, we assumed that the new derived
compounds should look similar to these ten compounds. With this assumption
the path probability was calculated. Setting t = 1 and h = 3, we generated two
Euler circuits and the corresponding chemical structure template is shown in Figure
6.3.17.
Figure 6.3.17: Two Euler circuits with the highest probability for the pre-image
VSMMD in Fig. 6.3.16 and the corresponding chemical structure templates.
6.3.5 Discussion
In order to investigate whether the pre-image VSMMD is reasonable, we performed
a more detailed analysis of the COX-2 data set. In the pre-image VSMMD as
shown in Figure 16, the cyclopentene ring can be found in one of the descriptors.
From medicinal chemistry studies, we know that cyclopentene derivatives are one
of the first series of diaryl-substituted cycles that have been well known as COX-
2 inhibitors [66, 82]. This empirical evidence demonstrates that our generated
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pre-image VSMMD is able to capture important properties of the ten most active
molecules.
When we perform a high throughput screening on the test set using the gener-
ated chemical structure template, the following molecule was identified as an exact
match to the template.
Figure 6.3.18: Matching molecule in the test set.
The molecule in Figure 6.3.18 has pIC50 values of 8.52, and it was one of the
highest active molecules in the testing set. From this result, we demonstrated that
our strategy was able to generate a high affinity molecule using only data in the
training set. We were able to claim that the generated molecule was a high affinity
molecule because it appeared as such in the testing set. In practice, the success of
the algorithm would have to be assessed by using a wet lab procedure to determine
the affinity of the generated molecule.
The inverse-QSAR procedure was applied to all eight data sets; the closest
matching molecule in the test set for the generated chemical template across 8 data
sets is shown in Figure 6.3.19. A quantitative evaluation of the generated molecules
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was performed by implicitly mapping the VSMMD of each molecule to the kernel
feature space for regression analysis. The regression results are also shown in Figure
6.3.19.
Figure 6.3.19: The closest matching molecule in the test set for the generated
chemical template across 8 data sets.
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6.4 Conclusion
In kernel-based learning, the usual assumption is that the data pairs {(xi, yi)}ni=1,
in the training set, come from a source that provides these samples in an indepen-
dent identically distributed (i.i.d.) fashion according to an unknown probability
distribution P (x, y). Furthermore, the test examples are assumed to come from the
same distribution [95]. In an ideal situation, the collection of molecular descriptors
in the training set follow a probability distribution that is only determined by the
interactions between ligands and the binding site. In practise this does not happen.
The selection of members in the training set may involve a significant amount of
bias due to human involvement in its creation:
• Selection of members of the training set may be restricted by rules that ex-
clude molecules that are not “drug like”.
• Since the training set involves molecules that have been assessed for binding
affinity, they had to be synthesized and may be part of a suite of molecules
for which the synthesis was not overly complicated.
• Furthermore, the molecular descriptors in the training set may show various
types of repetition, (for example, the repeated occurrence of some type of
scaffold). This may or may not be intended.
As a consequence of these issues, the learning algorithm will produce a predictor
that is taking into account both a biological process and the human activity intrin-
sic to the formation of the training set. More significantly, there is the demand
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that future test molecules come from the same probability distribution. Statisti-
cal learning theory will guarantee certain generalization bounds, but only if these
demands are met. In effect, the theory tells us that if test samples come from a
source, such as a virtual screening library that is not characterized by the same
rules of formation as the training set - then all bets are off.
In the constructive approach that has been described in this chapter, it is clear
that we are also limited by the information that is intrinsic to a training set. But
beyond this, the strategy significantly differs from virtual screening. Instead of
trying to find a new molecule in a database that should exhibit the same P (x, y)
characteristics, we side step this requirement (which may be difficult to guarantee)
and we build a new drug candidate using only the information that is strictly
contained in the training set itself.
While molecular fragments have been used in research studies for dealing with
quantitative structure-activity relationship problems, we have further evolved this
strategy to include a reverse engineering mechanism.
These mechanisms include:
1. The use of a kernel feature space algorithm to design or modify descriptor
image points in a feature space.
2. The deployment of a pre-image algorithm to map the descriptor image points
in the feature space back to the input space of the descriptors.
3. The design of a probabilistic strategy to convert new descriptors into mean-
ingful chemical graph templates.
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As reported in earlier chapters, our modeling has produced very effective al-
gorithms to predict drug-binding affinities and to predict multiple binding modes.
We have now extended our modeling approach to the development of algorithms
that derive new descriptors and then to facilitate the reverse engineering of such a
descriptor. This is a very desirable capability for a molecular descriptor.
Chapter 7
Conclusions
This thesis describes recent developments and applications of kernel based con-
structive ligand-based drug design. We have reached the following conclusion:
1. The “formation of descriptors” and the “computational modeling” problems
stated in Chapter 1 have been given a solution: we demonstrated that VS-
MMD was suitable for kernel studies in QSAR modeling. Our experiments
provided convincing comparative empirical evidence that this kernel method
can provide sufficient discrimination to predict various biological activities
of a molecule. The prediction ability of VSMMD was compared with other
descriptors and other kernel methods.
2. We have given a solution to the “component selection” problem: we devel-
oped a new filter based component selection algorithm, Kernel Alignment
Component Selection (KACS) based on kernel alignment for QSAR studies.
Furthermore, we have proven theoretically that our algorithm works well for
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finding the most important components. The reduced component set pro-
duced by KACS was compared with the reduced component set produced by
SVMRCE. Empirical results showed that our algorithm was able to find the
most important descriptor components in different QSAR data sets. The pre-
diction accuracies were substantially increased and compare favorably with
those from the earlier studies.
3. The “multiple binding modes” issue has been investigated: In conjunction
with a kernel based clustering algorithm, we extended the VSMMD to the
prediction of multiple binding modes, a challenging area of research that has
been previously studied by means of time consuming docking simulations.
The results reported in this study provided strong empirical evidence that our
strategy has enough resolving power to distinguish multiple binding modes
through the use of a kernel k-means algorithm.
4. The “library dependent” and the “reverse engineering of molecular descrip-
tor” issues have been given a solution: we developed a set of reverse en-
gineering strategies for QSAR modeling based on our VSMMD. The most
important aspect of our research is the presentation of strategies that actu-
ally generate the structure of a new drug candidate. This is substantially
different from methodologies that depend on database screening to get new
drug candidates. While our approach can support such an endeavor, it is not
our primary goal. In fact, it has not escaped our attention that database
screening, done via predictors derived from statistical learning algorithms, is
subject to procedural demands that are never discussed in any of the many
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papers that advocate the use of such machine learning. We are referring to
statistical learning theory that asserts the success of a predictor only when
the test sample is drawn from a data source that has the same probability
distribution as that characterizing the training set. In most applications of
statistical learning to database screening this is rarely, if ever, discussed. The
predictor is often applied to molecules in an application data set that have
very little relationship to the training data set. In these cases, the predictor
is optimistically treated as if it actually incorporates an algorithm that has
some firm and direct relationship to the biological context of the problem. In
our approach, we have managed to sidestep such concerns. While the training
set is still used to generate a new image point in the feature space, the reverse
engineering just described allows us to develop a new drug candidate that is
independent of issues related to probability distribution constraints placed in
the application data set.
In future work, it is of great interest to extend our VSMMD inverse-QSAR
algorithm to develop new algorithms that can include the multiple binding modes
information for new image point design in the feature space. In our current recovery
algorithm, we did not fully utilize the details of bonding information available from
the VSMMD. We will develop a new probabilistic model to retain the details of
bonding information for a better chemical template structure.
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